<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="methods-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2026.1741129</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Methods</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expert recommendations for setting and adjusting airway pressure release ventilation based on clinical experience and basic science evidence</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nieman</surname>
<given-names>Gary F.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/661016"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bates</surname>
<given-names>Jason H. T.</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/292832"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Andrews</surname>
<given-names>Penny L.</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1456785"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rose</surname>
<given-names>Louise</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shiber</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1916205"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Araos</surname>
<given-names>Joaquin</given-names>
</name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aurelien</surname>
<given-names>Ledoux</given-names>
</name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madden</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1787732"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manougian</surname>
<given-names>Toni</given-names>
</name>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Satalin</surname>
<given-names>Josh</given-names>
</name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Varpula</surname>
<given-names>Tero</given-names>
</name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3332774"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-khalisy</surname>
<given-names>Hassan</given-names>
</name>
<xref ref-type="aff" rid="aff10"><sup>10</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Markandaya</surname>
<given-names>Manjunath</given-names>
</name>
<xref ref-type="aff" rid="aff11"><sup>11</sup></xref>
<xref ref-type="aff" rid="aff12"><sup>12</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Pedro Leme</given-names>
</name>
<xref ref-type="aff" rid="aff13"><sup>13</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>da Fonseca Reis</surname>
<given-names>Luis Felipe</given-names>
</name>
<xref ref-type="aff" rid="aff14"><sup>14</sup></xref>
<xref ref-type="aff" rid="aff15"><sup>15</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3332516"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Downs</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="aff16"><sup>16</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2614086"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Camporota</surname>
<given-names>Luigi</given-names>
</name>
<xref ref-type="aff" rid="aff17"><sup>17</sup></xref>
<xref ref-type="aff" rid="aff18"><sup>18</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Habashi</surname>
<given-names>Nader M.</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1287178"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Surgery, Upstate Medical University</institution>, <city>Syracuse</city>, <state>NY</state>, <country country="us">United States</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Medicine, Larner College of Medicine, University of Vermont</institution>, <city>Burlington</city>, <state>VT</state>, <country country="us">United States</country></aff>
<aff id="aff3"><label>3</label><institution>Department Critical Care, University of Maryland Medical Center &#x2013; R Adams Cowley Shock Trauma Center</institution>, <city>Baltimore</city>, <state>MD</state>, <country country="us">United States</country></aff>
<aff id="aff4"><label>4</label><institution>Florence Nightingale Faculty of Nursing, Midwifery &#x0026; Palliative Care, King&#x2019;s College London</institution>, <city>London</city>, <country country="gb">United Kingdom</country></aff>
<aff id="aff5"><label>5</label><institution>Departments of Emergency Medicine, Neurology, and Surgery, University of Florida College of Medicine</institution>, <city>Jacksonville</city>, <state>FL</state>, <country country="us">United States</country></aff>
<aff id="aff6"><label>6</label><institution>Department of Clinical Sciences, College of Veterinary Medicine, Cornell University</institution>, <city>Ithaca</city>, <state>NY</state>, <country country="us">United States</country></aff>
<aff id="aff7"><label>7</label><institution>Department of Intensive Care, CHU HELORA - Jolimont</institution>, <city>La Louvi&#x00E8;re</city>, <country country="be">Belgium</country></aff>
<aff id="aff8"><label>8</label><institution>Department of Anesthesiology, Westchester Medical Center, New York Medical College</institution>, <city>Valhalla</city>, <state>NY</state>, <country country="us">United States</country></aff>
<aff id="aff9"><label>9</label><institution>Division of Intensive Care, Department of Anaesthesiology and Intensive Care, University of Helsinki and Helsinki University Hospital</institution>, <city>Helsinki</city>, <country country="fi">Finland</country></aff>
<aff id="aff10"><label>10</label><institution>Department of Internal Medicine, Division of Pulmonary Disease, Sleep and Critical Care Medicine, East Carolina University</institution>, <city>Greenville</city>, <state>NC</state>, <country country="us">United States</country></aff>
<aff id="aff11"><label>11</label><institution>Neurocritical Care, NorthEast Georgia Medical Center</institution>, <city>Gainesville</city>, <state>GA</state>, <country country="us">United States</country></aff>
<aff id="aff12"><label>12</label><institution>Department of Critical Care Medicine, MedStar St. Mary's Hospital</institution>, <city>Leonardtown</city>, <state>MD</state>, <country country="us">United States</country></aff>
<aff id="aff13"><label>13</label><institution>Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro</institution>, <city>Rio de Janeiro</city>, <country country="br">Brazil</country></aff>
<aff id="aff14"><label>14</label><institution>Postgraduate Program in Rehabilitation Sciences, Centro Universit&#x00E1;rio Augusto Mota (UNISUAM)</institution>, <city>Rio de Janeiro</city>, <country country="br">Brazil</country></aff>
<aff id="aff15"><label>15</label><institution>Intensive Care Unit, Central Hospital of the Military Police of the State of Rio de Janeiro</institution>, <city>Rio de Janeiro</city>, <country country="br">Brazil</country></aff>
<aff id="aff16"><label>16</label><institution>Department of Anesthesiology, University of Florida College of Medicine</institution>, <city>Gainesville</city>, <state>FL</state>, <country country="us">United States</country></aff>
<aff id="aff17"><label>17</label><institution>Centre for Human &#x0026; Applied Physiological Sciences, School of Basic &#x0026; Medical Biosciences, Shepherd's House, Guy's Campus, King&#x2019;s College London</institution>, <city>London</city>, <country country="gb">United Kingdom</country></aff>
<aff id="aff18"><label>18</label><institution>Guy&#x2019;s &#x0026; St Thomas&#x2019; NHS Foundation Trust</institution>, <city>London</city>, <country country="gb">United Kingdom</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Penny L. Andrews, <email xlink:href="mailto:pla@xmxmail.com">pla@xmxmail.com</email>; Josh Satalin, <email xlink:href="mailto:jms977@cornell.edu">jms977@cornell.edu</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-03">
<day>03</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>13</volume>
<elocation-id>1741129</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Nieman, Bates, Andrews, Rose, Shiber, Araos, Aurelien, Madden, Manougian, Satalin, Varpula, Al-khalisy, Markandaya, Silva, da Fonseca Reis, Downs, Camporota and Habashi.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Nieman, Bates, Andrews, Rose, Shiber, Araos, Aurelien, Madden, Manougian, Satalin, Varpula, Al-khalisy, Markandaya, Silva, da Fonseca Reis, Downs, Camporota and Habashi</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-03">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>We conducted a roundtable discussion and provided evidence-based guidance on the setting and adjustment of Airway Pressure Release Ventilation (APRV) in adult patients with acute respiratory distress syndrome (ARDS).</p>
</sec>
<sec>
<title>Methods</title>
<p>A panel of clinicians and basic scientists with extensive experience in lung physiology and using APRV was assembled to provide expert consensus guidance. The panel first established and agreed upon guiding principles for optimal APRV settings. To support consensus discussions, we then reviewed the literature on the physiological basis of APRV as a lung-protective ventilation strategy, as well as published APRV research. Finally, we held a one-day meeting and conducted robust, iterative consensus discussions using the Nominal Group Technique to reach agreement on the optimal APRV settings. This work represents an Expert Recommendation and Position Statement rather than a formal consensus guideline. The recommendations were developed through iterative expert discussions that integrated extensive clinical experience with supporting basic science evidence on time-controlled ventilation and alveolar mechanics. Recommendations were based on expert experience with APRV in the intensive care unit and supported by published animal and clinical studies.</p>
</sec>
<sec>
<title>Results</title>
<p>Consensus on initial APRV settings for acute lung injury (ALI) such as ARDS or disorders of normal or increased elstance was as follows: set the upper airway pressure (P<sub>High</sub>) to either plateau or peak inspiratory pressure when transitioning from volume control or pressure control/dual control, respectively; set the duration of P<sub>High</sub> (T<sub>High</sub>) to match the current respiratory rate on conventional ventilation; set lower airway pressure (P<sub>Low</sub>) to 0 cmH<sub>2</sub>O; and calculate duration of P<sub>Low</sub> (T<sub>Low</sub>) using the equation Peak Expiratory Flow x 75%&#x202F;=&#x202F;Termination of Expiratory Flow. Other recommendations included titrating these settings in response to changes in lung physiology and reaching consensus on injurious APRV settings that could impair gas exchange or cause lung instability.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The panel developed a protocol for adjusting the four APRV settings based on expert experience and solid clinical and scientific evidence for patients with ALI and ARDS, or disorders of normal or increased elastance. Optimizing the lung-protective settings in APRV mode can improve patient outcomes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>airway pressure release ventilation</kwd>
<kwd>APRV</kwd>
<kwd>ARDS</kwd>
<kwd>consensus recommendations</kwd>
<kwd>TCAV</kwd>
<kwd>time controlled adaptive ventilation</kwd>
<kwd>ventilator induced lung injury</kwd>
<kwd>VILI</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. Educational funds received from Drager Medical to support costs for consensus conference, including meals and conference supplies. No external support was received for manuscript preparation including any role in the content, analysis, wording or decision to publish.</funding-statement>
</funding-group>
<counts>
<fig-count count="11"/>
<table-count count="0"/>
<equation-count count="2"/>
<ref-count count="65"/>
<page-count count="19"/>
<word-count count="15442"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Pulmonary Medicine</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>Overview</title>
<p>Lung-protective ventilation aims to maintain adequate oxygenation and ventilation while reducing ventilator-induced lung injury (VILI) and related tissue damage, supported by evidence from both basic science research and clinical practice. To achieve this, 18 panelists [clinicians and basic scientists] were selected for their multidisciplinary expertise in acute respiratory distress syndrome (ARDS), mechanical ventilation, pulmonary physiology, and the clinical application of the mode airway pressure release ventilation (APRV). All those contacted had 5&#x2013;35&#x202F;years of experience with APRV. A summary of all panelists&#x2019; published work and biosketches is provided in <xref ref-type="supplementary-material" rid="SM1">Supplementary Files 1, 2</xref>.</p>
<p>This expert panel conference (<xref ref-type="supplementary-material" rid="SM1">Supplementary File 1</xref>) aimed to reach consensus on the clinical and experimental use setting and adjusting the APRV mode. The process of developing this consensus involved reviewing the evidence on the physiological basis for APRV as a lung-protective ventilation strategy, engaging in iterative discussions among panel members guided by Nominal Group Technique (NGT), and reaching final agreement on the optimal APRV settings.</p>
<p>Initially developed by Dr. John B. Downs [a faculty member at the conference] APRV was first introduced in 1987 (<xref ref-type="bibr" rid="ref1">1</xref>). However, despite nearly four decades of use, APRV still lacks a consistent or standardized method of delivery. Analyses of its 30-year evolution have shown significant variability in its application, making it challenging to define an optimal approach (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="ref2">2</xref>). Notably, many clinicians do not follow the most extensively studied method for setting and adjusting APRV, as highlighted in recent publications (<xref ref-type="bibr" rid="ref3">3</xref>). A meta-analysis confirmed this heterogeneity and the ongoing lack of consensus on APRV settings (<xref ref-type="bibr" rid="ref4">4</xref>). These findings emphasize the variability in clinical use of APRV and reflect a broader failure to incorporate key physiological and mechanistic insights into its implementation. The scientific evidence supporting the efficacy of APRV is reviewed in <xref ref-type="supplementary-material" rid="SM2">Supplementary File 2</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Pressure&#x2013;time waveforms from four published studies using airway pressure release ventilation (APRV) demonstrate marked heterogeneity in ventilator settings. Substantial variation exists in both pressure levels (P<sub>High</sub> and P<sub>Low</sub>) and duration of inspiration (T<sub>High</sub> and T<sub>Low</sub>), despite all being described as APRV (<xref ref-type="bibr" rid="ref2">2</xref>). <bold>(A)</bold> Stock (1987) shows 60 % continuous positive airway pressure (C<sub>PAP</sub>) with T<sub>Low</sub> of 1.27 seconds. B) Davis (1993) decreased the respiratory rate by prolonging both (T<sub>Low</sub>) of 1.27 seconds. <bold>(B)</bold> Davis (1993) decreased the respiratory rate by prolonging both T<sub>High</sub> and T<sub>Low</sub>. <bold>(C)</bold> Gama de Abreau (2010) simulated conventional ventilation with a brief T<sub>High</sub> and prolonged T<sub>Low</sub>. In contrast, <bold>(D)</bold> Roy (2013) shows a personalized, brief T<sub>Low</sub> and prolonged T<sub>High</sub> yielding 90 % C<sub>PAP</sub>. A recent meta-analysis reported that in 65% of clinical trials, expiratory time (T<sub>Low</sub>) was set arbitrarily rather than physiologically titrated (<xref ref-type="bibr" rid="ref4">4</xref>). Given that reducing tidal volume from 12 to 6&#x202F;mL/kg has been shown to reduce ARDS mortality, it follows that how APRV is configured and adjusted is also likely to have a major impact on clinical outcomes. Consequently, trials using APRV may produce widely divergent results depending on the specific implementation of the mode.</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Four line graphs depict airway pressure over time in seconds, labeled A to D. A (Stock 1987) and B (Davis 1993) show square waves with periods of high and low pressure. C (Gama De Abreu 2010) presents a wider low-pressure duration. D (Roy 2013) shows consistent high and low intervals, with narrower low periods compared to A and B.</alt-text>
</graphic>
</fig>
<p>There is considerable variation in how clinicians select and modify the core four APRV parameters: upper airway pressure (P<sub>High</sub>), the duration of P<sub>High</sub> (T<sub>High</sub>), lower airway pressure (P<sub>Low</sub>), and the duration of P<sub>Low</sub> (T<sub>Low</sub>). Notably, 65% (13 of 20) of the studies in the clinical research set used T<sub>Low</sub> arbitrarily, rather than established methods based on changes in lung pathophysiology (<xref ref-type="bibr" rid="ref4">4</xref>).</p>
<p>The lack of consensus and standardization presents significant challenges for delivering and evaluating the effectiveness of APRV, as specific configurations of its settings likely influence patient outcomes (<xref ref-type="bibr" rid="ref5">5</xref>). Although multiple small clinical trials have tested APRV, no trials have systematically analyzed outcomes by APRV setting and adjustment. Consequently, we could not perform a statistical (<xref ref-type="bibr" rid="ref6">6</xref>) or meta-analysis (<xref ref-type="bibr" rid="ref7">7</xref>) or support a Grading-Based recommendation (<xref ref-type="bibr" rid="ref8">8</xref>) as used in previous analyses of patient outcomes related to APRV settings and adjustments.</p>
<p>To address this gap, we held a consensus conference using the NGT, bringing together experienced clinicians who have used APRV for decades and have treated thousands of ARDS patients, both as a primary and a rescue ventilation mode. Their practical expertise offers valuable insights into optimizing APRV settings in clinical practice.</p>
</sec>
<sec sec-type="intro" id="sec2">
<title>Introduction</title>
<p>Despite extensive investigation over the past 25&#x202F;years, including the Acute Respiratory Distress Syndrome Network (ARDSNet) study, randomized controlled trials (RCTs) and meta-analyses have consistently shown no significant reduction in mortality among patients with established ARDS (<xref ref-type="bibr" rid="ref15 ref16 ref17 ref18">15&#x2013;18</xref>). This persistent mortality underscores the limitations of current protective ventilation strategies, including recruitment maneuvers (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref18">18</xref>) and highlights the need for alternative approaches.</p>
<p>The APRV mode, first introduced in 1987 (<xref ref-type="bibr" rid="ref1">1</xref>), is one such alternative. It has strong supporting evidence from basic science demonstrating its physiological benefits (<xref ref-type="supplementary-material" rid="SM1">Supplementary Files 1, 2</xref>). However, the lack of standardized clinical guidelines for setting and adjusting APRV has limited its wider use and thorough evaluation. To address this, we formed an expert consensus panel comprising experienced clinicians who have extensively used APRV and scientists who have studied the mechanics of time-controlled ventilation for decades.</p>
<p>A major challenge in evaluating APRV&#x2019;s effectiveness is the wide variation in how it is defined and implemented across clinical studies and practice, particularly with respect to ventilator settings (<xref ref-type="bibr" rid="ref4">4</xref>). This inconsistency leads to disparate physiological and clinical outcomes, making it difficult to assess the benefits and risks of APRV accurately. This paper aims to address this issue by reaching expert consensus on the definition and use of APRV settings to ensure consistent application and interpretation in both research and clinical practice.</p>
<p>An extensive review has addressed misconceptions about APRV, countering claims of increased barotrauma, volutrauma, or right heart dysfunction (<xref ref-type="bibr" rid="ref19">19</xref>). Additionally, APRV has been shown to improve secretion clearance, potentially reducing ventilator-associated pneumonia rates (<xref ref-type="bibr" rid="ref20">20</xref>). Evidence indicates that APRV may be at least non-inferior (<xref ref-type="bibr" rid="ref21">21</xref>) and possibly superior (<xref ref-type="bibr" rid="ref22">22</xref>) compared to conventional ventilation strategies. Meta-analyses of RCTs favor APRV over low tidal volume ventilation (LV<sub>T</sub>) as a lung-protective method (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). Furthermore, mechanistic data suggest that APRV reduces stress and strain in distal airspaces and improves ventilation uniformity (<xref ref-type="supplementary-material" rid="SM2">Supplementary File 2</xref>).</p>
</sec>
<sec id="sec3">
<title>Supporting science</title>
<p>The basic science literature on the mechanisms of ARDS pathophysiology and how these injuries predispose the lung to secondary VILI is reviewed in <xref ref-type="supplementary-material" rid="SM3">Supplementary File 3</xref>. The mechanisms by which inspiratory and expiratory times can stabilize and reopen the acutely injured lung, thereby reducing VILI, are also discussed.</p>
<p>To evaluate the effectiveness of APRV, tables were created listing published studies comparing APRV with other modes in both animal models and humans, as well as computational models of time-controlled ventilation (see <xref ref-type="supplementary-material" rid="SM4">Supplementary Files 4-7</xref>). These tables are organized into categories: clinical trials (<xref ref-type="supplementary-material" rid="SM4">Supplementary File 4</xref>), animal studies (<xref ref-type="supplementary-material" rid="SM5">Supplementary File 5</xref>), computational modeling studies (<xref ref-type="supplementary-material" rid="SM6">Supplementary File 6</xref>), and meta-analyses (<xref ref-type="supplementary-material" rid="SM7">Supplementary File 7</xref>). Whenever possible, APRV settings were extracted and included in the tables. The primary outcome parameters selected by each publication&#x2019;s authors are listed in the tables. The authors&#x2019; assessments of APRV&#x2019;s impact, compared to conventional ventilation controls on these outcome parameters, were recorded as Negative (A&#x2014;Statistically inferior), Neutral (B&#x2014;Not statistically different), or Positive (C&#x2014;Statistically superior) relative to the control ventilation group. These <xref ref-type="supplementary-material" rid="SM4">Supplementary Files 4-7</xref> serve as a resource compiling the published literature on APRV and time-controlled ventilation.</p>
</sec>
<sec sec-type="methods" id="sec4">
<title>Methods</title>
<sec id="sec5">
<title>Committee composition and consensus</title>
<p>Our clinical panel included pulmonologists, anesthesiologists, nurses, respiratory therapists, and intensivists, all selected for their extensive experience treating patients with ARDS using APRV in both primary and rescue mechanical ventilation modes. The basic science panel comprised pulmonary physiologists and lung bioengineers who have investigated the physiological role of time-controlled lung mechanics and its pathophysiological implications.</p>
<p>Draft statements were developed by the organizing committee and iteratively refined through structured, moderated discussions and post-conference feedback. Consensus was pre-defined as agreement by at least 75% of panel members on a given statement following structured debate. Statements that did not meet this threshold during the initial voting round were revised based on panel feedback and re-circulated for additional discussion and voting until the predefined level of agreement was achieved or the statement was excluded.</p>
</sec>
<sec id="sec6">
<title>Formulating the questions</title>
<p>As a first step, the committee agreed that their focus would be on guidance for setting and adjusting the four key parameters of the APRV mode: the upper airway pressure (P<sub>High</sub>), the duration of P<sub>High</sub> (T<sub>High</sub>), the lower airway pressure (P<sub>Low</sub>), and the duration of P<sub>Low</sub> (T<sub>Low</sub>).</p>
</sec>
<sec id="sec7">
<title>Consensus building methods</title>
<p>Expert-based cooperative analysis (EbCA) represents a significant improvement in healthcare decision-making, particularly given the complexity of healthcare systems (<xref ref-type="bibr" rid="ref25">25</xref>). EbCA uses &#x201C;expert knowledge&#x201D; to improve clinical decisions by combining available clinical and scientific data with insights obtained from extensive practical experience with specific treatment methods in particular patient groups (<xref ref-type="bibr" rid="ref26">26</xref>).</p>
<p>Unlike &#x201C;expert opinion,&#x201D; which is often subjective, &#x201C;expert knowledge&#x201D; is grounded in accumulated clinical experience and offers a higher level of evidence (<xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref26">26</xref>). Additionally, while evidence-based medicine has traditionally emphasized RCTs, it has been criticized for being too rigid (<xref ref-type="bibr" rid="ref26">26</xref>). Observational studies can complement RCT results, thereby improving the quality of evidence and strengthening clinical decision-making (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
<p>The process began with panelists independently generating ideas in response to our predefined questions about APRV settings and adjustments. These ideas were then shared in a round-robin manner and recorded verbatim. Scientific evidence supporting APRV settings was incorporated into the discussion, providing a solid foundation for their arguments (<xref ref-type="supplementary-material" rid="SM2">Supplementary File 2</xref>). An iterative group discussion was held to ensure a shared understanding, during which clinical participants shared the APRV settings they found most useful in their practice.</p>
<p>Each of the four APRV settings was reviewed sequentially, with both its individual effects and overall impact analyzed. After each discussion, the leader (Habashi) summarized key points and identified the approach supported by the strongest clinical and scientific evidence. Once consensus was reached, the group moved on to the next setting. If consensus was not initially achieved, additional discussion was held until agreement was reached. All faculty members contributed to the final manuscript through edits and additions.</p>
</sec>
</sec>
<sec sec-type="results" id="sec8">
<title>Results</title>
<sec id="sec9">
<title>Consensus recommendations for specific APRV settings</title>
<p>The consensus group developed recommendations for setting and adjusting the APRV mode, supported by strong experimental evidence (<xref ref-type="supplementary-material" rid="SM2">Supplementary File 2</xref>), where studies using relevant animal models have demonstrated significant improvements in lung protection and patient outcomes (<xref ref-type="bibr" rid="ref28">28</xref>). Additionally, <italic>in vivo</italic> microscopy and histological analyses have documented the beneficial effects of precise inspiratory and expiratory timing on alveolar stability and the lung microenvironment (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref13">13</xref>). Computational models have further clarified how changes in timing and pressure settings influence lung mechanics and stress distribution (<xref ref-type="bibr" rid="ref29 ref30 ref31 ref32 ref33 ref34">29&#x2013;34</xref>), supported by biological data analysis (<xref ref-type="bibr" rid="ref35">35</xref>, <xref ref-type="bibr" rid="ref36">36</xref>).</p>
<p>The committee&#x2019;s recommended settings aim to stabilize alveoli, maintain end-expiratory lung volume (EELV), and prevent the onset of the so-called &#x201C;VILI vortex.&#x201D; (<xref ref-type="bibr" rid="ref37">37</xref>) Specifically, prolonged T<sub>High</sub> facilitates gradual recruitment of collapsed lung regions, while a carefully set T<sub>Low</sub> prevents derecruitment (<xref ref-type="bibr" rid="ref38">38</xref>). These settings are designed to use time and pressure strategically to maintain alveolar stability and progressively reopen collapsed lung tissue (<xref ref-type="bibr" rid="ref39">39</xref>).</p>
<sec id="sec10">
<title>Question 1: what is the optimal method for setting P<sub>High</sub>?</title>
<sec id="sec11">
<title>Background</title>
<p>The pressure&#x2013;time and flow-time curves seen during APRV are shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. P<sub>High</sub> denotes the pressure inflating the lung, with lung volume changing with respiratory system compliance (C<sub>RS</sub>) and the duration (T<sub>High</sub>) of the applied pressure (P<sub>High</sub>). These together define the continuous positive airway pressure (CPAP) phase of APRV (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Typical airway pressure release ventilation (APRV) pressure&#x2013;time and gas flow-time curves using the time-controlled adaptive ventilation TCAV method. An extended continuous airway pressure (CPAP) phase (P<sub>High</sub>/T<sub>High</sub>) and a very brief release phase (P<sub>Low</sub>/T<sub>Low</sub>) with an inhalation to exhalation (I:E) ratio as high as 12:1. The low airway pressure (P<sub>Low</sub>) is always set to 0 cmH<sub>2</sub>O. However, the release phase is so brief that the lung does not have enough time to depressurize to atmospheric pressure, so a time-controlled PEEP (TC-PEEP) is maintained. Although P<sub>Low</sub> is set at 0 cmH<sub>2</sub>O TC-PEEP at end-expiration (red dotted line), it is approximately half of the P<sub>High</sub>. The T<sub>Low</sub> setting is influenced by changes in respiratory system compliance (C<sub>RS</sub>), which is measured as the slope of the expiratory flow curve (Slope<sub>EF</sub>). T<sub>Low</sub> is calculated by multiplying the peak expiratory flow (F<sub>PE</sub>) by a cofactor (75%) to determine the termination of expiratory flow (F<sub>EE</sub>), indicated by the red arrowhead (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>; F<sub>PE</sub> x 0.75&#x202F;=&#x202F;F<sub>EE</sub>). As lung disease progresses, C<sub>RS</sub> decreases, leading to increased lung recoil and Slope<sub>EF</sub>, reducing T<sub>Low</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Graph showing respiratory pressure and gas flow over time during ventilation. The top panel depicts periods of CPAP and release phases, with ventilator pressure peaking at 30 cm H2O and TC PEEP around 10 cm H2O. The bottom panel shows gas flow oscillations, peaking at 50 L/min, with a labeled slope of expiratory flow. Both panels illustrate changes between CPAP and release phases over eight seconds.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec12">
<title>Summary of basic science evidence</title>
<p>To our knowledge, only two translational animal studies have investigated the APRV mode, examining how variations in P<sub>High</sub> affect lung injury and inflammation (<xref ref-type="bibr" rid="ref40">40</xref>, <xref ref-type="bibr" rid="ref41">41</xref>). Both studies used a heterogeneous porcine lung injury model of surfactant deactivation, which included both normal lung areas and areas with surfactant deactivation simulating ARDS. This setup allowed for assessing the pathological impact of lung overdistension (OD) and recruitment-derecruitment (RD) in both normal and surfactant-depleted tissues.</p>
<p>Four groups of animals were studied, with mechanical breaths set in the APRV mode to induce lung overdistension (OD) (OD&#x2191;; P<sub>High</sub>&#x202F;=&#x202F;40 cmH<sub>2</sub>O) or not (OD&#x2193;; P<sub>High</sub>&#x202F;=&#x202F;28 cmH<sub>2</sub>O), and lung recruitment-derecruitment (RD) or not. The RD was caused (RD&#x2191;) or prevented (RD&#x2193;) by controlling the end-expiratory flow termination (F<sub>EE</sub>) point, by altering the expiratory time (T<sub>Low</sub>). The exact expiratory time was determined using the peak expiratory flow (F<sub>PE</sub>) equation: [F<sub>PE</sub> x 25% (RD&#x2191;) or 75% (RD&#x2193;)]&#x202F;=&#x202F;F<sub>EE</sub>. A higher percentage (75%) resulted in a shorter expiratory time. The expiratory time (T<sub>Low</sub>) was set sufficiently brief to prevent alveolar collapse (RD&#x2193;), according to the equation,<disp-formula id="E1">
<mml:math id="M1">
<mml:msub>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi>PE</mml:mi>
</mml:msub>
<mml:mo>&#x00D7;</mml:mo>
<mml:mn>75</mml:mn>
<mml:mo>%</mml:mo>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi>EE</mml:mi>
</mml:msub>
</mml:math>
<label>(1)</label>
</disp-formula>which resulted in a very brief expiratory duration. The (T<sub>Low</sub>) was set sufficiently long to cause alveolar collapse (RD&#x2191;) using the equation (<xref ref-type="bibr" rid="ref41">41</xref>).<disp-formula id="E2">
<mml:math id="M2">
<mml:msub>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi>PE</mml:mi>
</mml:msub>
<mml:mo>&#x00D7;</mml:mo>
<mml:mn>25</mml:mn>
<mml:mo>%</mml:mo>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi>EE</mml:mi>
</mml:msub>
</mml:math>
<label>(2)</label>
</disp-formula></p>
<p>This study did not evaluate efficacy or outcomes but aimed to identify the roles of the two main mechanisms of VILI, specifically OD and RD, on inflammation and pathophysiology. A P<sub>High</sub> of 40 cmH<sub>2</sub>O, with or without RD, was found not to cause pulmonary edema in normal tissue and only induced edema in surfactant deactivation tissue when OD was combined with RD. A similar porcine ARDS model confirmed that P<sub>High</sub> 40 cmH<sub>2</sub>O does not damage normal lung tissue and becomes problematic only when combined with RD (<xref ref-type="bibr" rid="ref40">40</xref>).</p>
<p>A similar porcine ARDS model confirmed that a P<sub>High</sub> of 40 cmH<sub>2</sub>O does not damage normal lung tissue and only becomes problematic when combined with alveolar instability (RD) (<xref ref-type="bibr" rid="ref40">40</xref>). This supports the conclusion that overdistending normal tissue (i.e., the Baby Lung) is not the primary cause of VILI (<xref ref-type="bibr" rid="ref41 ref42 ref43 ref44 ref45">41&#x2013;45</xref>). This is because the Baby Lung in the ARDS patient is not normal tissue, similar to that in the animal studies described. Instead, it has heterogeneously distributed lesions of unstable, collapsed, or edema-filled alveoli that standard clinical imaging methods cannot detect. These lesions have been called &#x201C;Hidden Microatelectasis&#x201D; and function as stress multipliers that correlate with VILI. Maintaining P<sub>High</sub> below 30 cmH<sub>2</sub>O during normal chest wall compliance (C<sub>CW</sub>) reduces lung tissue damage in areas of surfactant deactivation when a brief expiratory duration prevents alveolar collapse (RD). These studies thus demonstrate that normal lung tissue is highly resistant to damage from high airway pressures, provided cyclic collapse and reopening are avoided.</p>
</sec>
<sec id="sec13">
<title>Recommendation</title>
<p>P<sub>High</sub> should be sustained during the steep portion of the pressure-volume curve between functional residual capacity (FRC) and total lung capacity (TLC). Therefore, P<sub>High</sub> should be set equal to plateau pressure (P<sub>Plat</sub>) when switching from volume control (VC) mode, to the peak inspiratory pressure (PIP) when switching from pressure control (PC) or dual targeted (DT) mode such as pressure regulated pressure control (PRVC) or mean airway pressure (Paw) plus 2&#x2013;4 cmH<sub>2</sub>O when using the high frequency oscillatory ventilation (HFOV) mode. When using APRV as the initial mode, P<sub>High</sub> recommendations are Mild ARDS (20&#x2013;24 cmH<sub>2</sub>O), Moderate ARDS (25&#x2013;29 cmH<sub>2</sub>O), and Severe ARDS (26&#x2013;30 cmH<sub>2</sub>O), with the possibility of exceeding 30 cmH<sub>2</sub>O with low C<sub>RS</sub>.</p>
<p>Although tidal volume (V<sub>T</sub>) is not targeted, it is important to note that V<sub>T</sub> is generally &#x003C;6&#x202F;mL/kg in a severely injured lung (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), as described in detail under the T<sub>Low</sub> setting section. With decreased C<sub>RS</sub> / increased E<sub>RS</sub>, the V<sub>T</sub> may be &#x003C;4&#x202F;mL/kg. In this instance, the P<sub>High</sub> may be increased in 2 cmH<sub>2</sub>O increments to achieve a minimum V<sub>T</sub> of 5&#x2013;6&#x202F;mL/kg.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Utilizing the time-controlled adaptive ventilation (TCAV) method to set and adjust the time at low airway pressure (T<sub>Low</sub>) with the airway pressure release ventilation (APRV) mode personalizes: (1) expiratory duration (T<sub>Low</sub>), (2) tidal volume (V<sub>T</sub>), and (3) time-controlled PEEP (TC-PEEP). <bold>(A)</bold> With mild lung injury, the moderately reduced respiratory system compliance (C<sub>RS</sub>) is represented by a thin spring within the chest. This results in low lung recoil, and end-expiratory lung volume (EELV) is only moderately lowered. The expiratory gas flow-time curve (blue) observed on the ventilator monitor can be used to assess lung pathophysiology, as with spirometry. A shallow slope of the expiratory flow curve (Slope<sub>EF</sub>) indicates normal C<sub>RS,</sub> while a steep slope indicates low C<sub>RS</sub>. With mild lung injury, the Slope<sub>EF</sub> is shallow (45&#x00B0;). <xref ref-type="disp-formula" rid="E1">Equation 1</xref> (F<sub>PE</sub> x 75%&#x202F;=&#x202F;F<sub>EE</sub>) is used to calculate T<sub>Low</sub>. In this example, the F<sub>PE</sub>&#x202F;=&#x202F;&#x2212;60&#x202F;L/min, so the clinician would set the F<sub>EE</sub> at &#x2212;45&#x202F;L/min (60&#x202F;L/min x 75%&#x202F;=&#x202F;45&#x202F;L/min). The duration from F<sub>PE</sub> to F<sub>EE</sub> is used to set T<sub>Low</sub>. In this case, T<sub>Low</sub>&#x202F;=&#x202F;0.48&#x202F;s. The relatively long T<sub>Low</sub> allows a larger volume of gas to be released (V<sub>R</sub>), resulting in a lower TC-PEEP and higher V<sub>T</sub> (&#x003E;6&#x202F;cc/kg). <bold>(B)</bold> Severe ARDS has developed in the same patient, characterized by a very low C<sub>RS</sub>, high lung recoil (thick spring inside the chest), and loss of EELV (dotted chest wall outline). The same equation (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>) is used to calculate T<sub>Low</sub>. However, the high lung recoil quickly expels air from the lung, resulting in a steep Slope<sub>EF</sub> (30&#x00B0;). Rapid gas exhalation causes F<sub>EE</sub> to be reached quickly, thereby decreasing T<sub>Low</sub> (0.35&#x202F;s). The brief T<sub>Low</sub> results in a small V<sub>R</sub>, leading to a higher TC-PEEP and lower V<sub>T</sub> (&#x003C;6&#x202F;cc/kg), precisely what is needed to protect a severely injured lung. To summarize, T<sub>Low</sub>, V<sub>T</sub>, and TC-PEEP are personalized and adjusted based on the patient&#x2019;s lung pathophysiology, as indicated by lung spirometry (Slope<sub>EF</sub>) (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref64">64</xref>).</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Diagram comparing mild lung injury and severe ARDS. Panel A shows normal lung expiration leading to a higher tidal volume above six cubic centimeters per kilogram. Panel B illustrates severe ARDS with below-normal expiration resulting in a lower tidal volume below six cubic centimeters per kilogram. Both panels include graphs depicting expiration flow and time, with differing slopes indicating changes in lung function.</alt-text>
</graphic>
</fig>
<p>Before transitioning to APRV, it is advisable to evaluate the patient&#x2019;s intravascular status to assess preload dependency, for example, with the passive leg raise maneuver (<xref ref-type="bibr" rid="ref46">46</xref>). Data show that patients with positive preload dependency respond effectively to a fluid bolus without developing pulmonary edema (<xref ref-type="bibr" rid="ref47">47</xref>).</p>
<p>Because lung recruitment can occur rapidly, monitor lung volume on chest radiograph. Check the diaphragm&#x2019;s shape, which should typically reach its maximum at the mid-clavicular line, crossing the fifth anterior rib. If the diaphragms start to flatten&#x2014;that is, if the peak curvature moves medially from the mid-clavicular line&#x2014;reduce P<sub>High</sub> by 2&#x2013;3 cmH&#x2082;O. Then, adjust T<sub>Low</sub> as needed to keep the fraction of F<sub>EE</sub> at 75% of the F<sub>PE</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>) (See T<sub>Low</sub> adjustment below).</p>
</sec>
<sec id="sec14">
<title>Justifications and implementation considerations</title>
<p>The above recommendations align with those for standard mechanical ventilation, namely maintaining P<sub>High</sub>&#x202F;&#x2264;&#x202F;30 cmH&#x2082;O with normal C<sub>CW</sub>. This approach is consistent with all ventilation mode guidelines and should not cause lung injury, as with other modes. Raising P<sub>High</sub> above 30 cmH&#x2082;O may be necessary for patients with low C<sub>CW</sub>, such as those with significant central obesity, ascites, or abdominal distension (<xref ref-type="bibr" rid="ref48">48</xref>).</p>
<p>A practical method is to gradually increase P<sub>High</sub> in 2 cmH&#x2082;O steps while monitoring changes in C<sub>RS</sub> and driving pressure (&#x0394;P) (&#x0394;P&#x202F;=&#x202F;V<sub>T</sub>/C<sub>RS</sub>). It is essential to recognize that positive changes in C<sub>RS</sub> and P may take considerable time to manifest if lung reopening occurs gradually, suggesting prolonged opening time constants. In these cases, APRV gradually opens the lung (<xref ref-type="bibr" rid="ref49">49</xref>).</p>
</sec>
<sec id="sec15">
<title>Future research opportunities</title>
<p>Future research opportunities include further studies on using esophageal manometry to estimate pleural pressure (P<sub>PL</sub>). This method would allow P<sub>High</sub> to be set above 30 cmH<sub>2</sub>O in patients with low C<sub>CW,</sub> reducing concerns about overdistension by providing a direct measurement of transpulmonary pressure (P<sub>TP</sub>). The ARDSNet protocol was found to be less lung protective than the APRV mode set by the time-controlled adaptive ventilation (TCAV) method and guided by P<sub>TP</sub> in a clinically relevant porcine model of sepsis and gut ischemia/reperfusion (<xref ref-type="bibr" rid="ref50">50</xref>).</p>
</sec>
</sec>
<sec id="sec16">
<title>Question 2: what is the optimal method for setting P<sub>Low</sub>?</title>
<sec id="sec17">
<title>Background</title>
<p>During conventional mechanical ventilation, the positive end-expiratory pressure (PEEP) applied by the ventilator is the end-expiratory pressure during each breath cycle. Setting P<sub>Low</sub> to 0 cmH&#x2082;O with APRV using T<sub>Low</sub> calculated as a fraction of F<sub>EE</sub> at 75% of F<sub>PE</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>) does not create a PEEP of 0 cmH&#x2082;O because expiration is too brief for the expiratory flow to cease and the lungs to depressurize fully. This results in a time-controlled PEEP (TC-PEEP) (<xref ref-type="fig" rid="fig2">Figure 2</xref>, red dashed line). In a translational large-animal model, a P<sub>Low</sub> of 0 cmH&#x2082;O yielded a significant TC-PEEP, slightly more than half the P<sub>High</sub> (<xref ref-type="bibr" rid="ref50">50</xref>).</p>
<p>A brief expiratory duration, rather than a fixed pressure (PEEP), stabilizes alveoli because the expiratory time is shorter than the lung&#x2019;s fastest time constant of closure. Therefore, setting P<sub>Low</sub> above 0 cmH&#x2082;O is unnecessary and may be harmful, as it can increase PaCO&#x2082; levels and hinder clearance of secretions by slowing expiratory gas flow (<xref ref-type="bibr" rid="ref51">51</xref>). Unlike PEEP in traditional ventilation, T<sub>Low</sub> dynamically adjusts EELV (<xref ref-type="bibr" rid="ref14">14</xref>), providing a physiologically responsive method that better adapts to changes in lung mechanics than compliance-based adjustments, arbitrary scales, or oxygenation targets, which have limited predictive value for patient outcomes (<xref ref-type="bibr" rid="ref52">52</xref>).</p>
<p>Setting a P<sub>Low</sub> above 0 cmH<sub>2</sub>O creates expiratory resistance, reducing gas flow and causing two major issues:<list list-type="order">
<list-item>
<p>Reduced expiratory flow limits CO&#x2082; elimination per breath, and when combined with a brief T<sub>Low</sub>, can cause hypercapnia.</p>
</list-item>
<list-item>
<p>Expiratory flow when unimpeded by a set PEEP is a measure of C<sub>RS</sub> and can be used to determine the correct T<sub>Low</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>). Adding resistance (setting a P<sub>Low</sub>) breaks this link, potentially leading to an incorrect T<sub>Low</sub> setting. An excessively long T<sub>Low</sub> has been shown to increase the risk of RACE-induced atelectrauma (<xref ref-type="bibr" rid="ref41">41</xref>).</p>
</list-item>
</list></p>
<p>Thus, maintaining P<sub>Low</sub> at 0 cmH<sub>2</sub>O is crucial for maintaining dynamic, patient-specific control of EELV and reducing the risk of ventilator-induced lung injury in APRV.</p>
</sec>
<sec id="sec18">
<title>Summary of basic science evidence</title>
<p>In a translational porcine ARDS model comparing ARDSnet LV<sub>T</sub> with APRV, it was observed that 48&#x202F;h after injury (peritoneal sepsis plus gut ischemia/reperfusion), using P<sub>Low</sub>&#x202F;=&#x202F;0 cmH<sub>2</sub>O resulted in a TC-PEEP of 17.8&#x202F;&#x00B1;&#x202F;2.0 cmH<sub>2</sub>O. The lung remained well-inflated, and ARDS was prevented (<xref ref-type="fig" rid="fig4">Figure 4</xref>) (<xref ref-type="bibr" rid="ref50">50</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Gross lung photos at the end of a 48-h (T48) porcine sepsis plus ischemia/reperfusion acute respiratory distress syndrome (ARDS) model using the airway pressure release ventilation (APRV) mode set with the time-controlled adaptive ventilation (TCAV) method <bold>(A)</bold> or the ARDSnet low tidal volume (LV<sub>T</sub>) method <bold>(B)</bold>. Driving pressure (&#x0394;P), tidal volume (V<sub>T</sub>), and respiratory system compliance (C<sub>RS</sub>) values over time for each mode <bold>(C,D)</bold> (<xref ref-type="bibr" rid="ref28">28</xref>). <bold>(A)</bold> Forty-eight hours post-injury, the TCAV method displayed fully inflated lungs with no edema on the cut lung surface. <bold>(B)</bold> The ARDSNet method demonstrated significant atelectasis and edema on the cut lung surface. The V<sub>T</sub> in the APRV group was 12&#x202F;mL/kg at T48, but the &#x0394;P was only 9 cmH<sub>2</sub>O because the C<sub>RS</sub> remained elevated (&#x0394;P=Vt/C<sub>RS</sub>).</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Four-panel figure showing comparisons between lungs and graphs. Panel A shows healthy lungs, while panel B shows damaged, discolored lungs. Panels C and D display graphs. Panel C, titled "Compliance," shows a line graph comparing compliance over time between APRV and LVI. Panel D, titled "Driving Pressure and Tidal Volume," shows a line graph comparing driving pressure and tidal volume over time between APRV and LVI. The graphs include time points from baseline to 48 hours.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec19">
<title>Recommendation</title>
<p>The P<sub>Low</sub> should always be set to 0 cmH<sub>2</sub>O, but PEEP will be maintained because of the brief expiratory period (TC-PEEP) (<xref ref-type="fig" rid="fig2">Figure 2</xref>, red dashed line) (<xref ref-type="bibr" rid="ref50">50</xref>). Setting P<sub>Low</sub> to 0 cmH<sub>2</sub>O also improves CO<sub>2</sub> clearance and mucus removal. A P<sub>Low</sub> of 0 cmH<sub>2</sub>O enables expiratory flow to identify lung C<sub>RS</sub>, similar to spirometry, on a breath-by-breath basis for precise setting and adjustment of T<sub>Low</sub>.</p>
</sec>
<sec id="sec20">
<title>Justifications and implementation considerations</title>
<p>Direct observation of subpleural alveoli shows that a P<sub>Low</sub> of 0 cmH<sub>2</sub>O does not cause RACE when T<sub>Low</sub> is determined using a fraction of F<sub>EE</sub> at 75% of F<sub>PE</sub> (<xref ref-type="fig" rid="fig5">Figure 5</xref>, II). Although P<sub>Low</sub> is set to 0 cmH<sub>2</sub>O, the lung does not have enough time to depressurize, maintaining a TC-PEEP (<xref ref-type="fig" rid="fig2">Figure 2</xref>, red dashed line) (<xref ref-type="bibr" rid="ref50">50</xref>). Research indicates that alveoli are better stabilized with a brief expiratory time that generates TC-PEEP compared to using a non-zero PEEP level with a longer expiratory duration that results in the same end-expiratory lung volume (<xref ref-type="supplementary-material" rid="SM3">Supplementary File 3, Figure S9</xref>) (<xref ref-type="bibr" rid="ref5">5</xref>). In the acutely injured lung, gas distribution within the alveoli and ducts closely resembles normal conditions, with a P<sub>Low</sub> of 0 cmH<sub>2</sub>O and a T<sub>Low</sub> set using <xref ref-type="disp-formula" rid="E1">Equation 1</xref> (<xref ref-type="fig" rid="fig5">Figure 5</xref>, I). This results in dynamic alveolar homogeneity similar to that of a normal lung (<xref ref-type="bibr" rid="ref11">11</xref>), thereby facilitating CO<sub>2</sub> and mucus removal (<xref ref-type="bibr" rid="ref5">5</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The impact of ventilatory modes and settings on alveolar and alveolar duct histology and real-time subpleural alveolar opening and collapse. Airway pressure release ventilation (APRV) mode set at different expiratory times (T<sub>Low</sub>) (APRV 10% &#x2013; long T<sub>Low</sub>, APRV 75% &#x2013; brief T<sub>Low</sub>, see <xref ref-type="disp-formula" rid="E1 E2">Equations 1, 2</xref>) and the volume-controlled ventilation (VCV) mode with a low tidal volume (V<sub>T</sub>) of 6&#x202F;mL/kg and two levels of positive end-expiratory pressure (PEEP) at PEEP 5 and PEEP 16 cmH<sub>2</sub>O. In APRV mode, the expiratory time (T<sub>Low</sub>) was determined by <xref ref-type="disp-formula" rid="E1">Equation 1</xref>: peak expiratory flow (F<sub>PE</sub>) multiplied by a cofactor (10% or 75%) to establish expiration termination: F<sub>PE</sub>&#x202F;&#x00D7;&#x202F;10% or 75%&#x202F;=&#x202F;F<sub>EE</sub>. Using a 10% cofactor prolongs the expiratory duration, whereas a 75% cofactor yields a very brief duration; the 75% cofactor is used in the time-controlled adaptive (TCAV) method. <bold>I&#x2014;</bold>In this study, Tween was lavaged into the lungs to deactivate pulmonary surfactant, serving as an established model for ARDS, and one lung was fixed at inspiration. In contrast, the other was fixed at expiration. <bold>(A,B)</bold> A color-coding scheme is used to distinguish between alveolar ducts (green), alveoli (blue), and tissue (red) for computer image analysis. <bold>(C)</bold> The impact of the two ventilator modes and the four ventilator settings on duct and alveolar size at inspiration and expiration is compared to an uninjured (no Tween) control group. Gas distribution in the alveolar tissue is highest in the control group, with 68% during inspiration (I) and 50% during expiration (E), as measured by computer image analysis of the histologic slide. The alveolar duct volume was slightly under 19%-I and 16%-E; the remaining area was tissue. Tween injury increased duct volume in all groups, whereas alveolar volume decreased. APRV 75% yielded the gas distribution closest to control (ducts at 30%-I and 25%-E, and alveoli at 49%-I and 48%-E). APRV 10% was the least effective at alveolar ventilation, with duct occupancy at 50%-I and 35%-E and alveoli at 27%-I and 29%-E. The disparity between inspiratory and expiratory occupancies reflects dynamic strain (atelectrauma), which is significantly elevated in the alveolar ducts of the APRV 10% group. It was also found that the micro-strain (<italic>&#x03B5;</italic>-strain) was 0.14 in the control group, increased to 0.20 in the APRV 75% group, and rose significantly to 0.39 in the APRV 10% group. The &#x03B5;-strain for PEEP 5 was 0.34, and PEEP 16 was 0.23. This indicates that APRV 75% with a very brief expiratory time (T<sub>Low</sub>) is most effective at normalizing gas distribution and reducing &#x03B5;-strain in an acutely injured lung. The very different impact of the APRV mode with different expiratory durations (APRV10% &#x2013; long T<sub>Low</sub> and APRV 75% -very brief T<sub>Low</sub>) on lung histopathology and dynamic alveolar mechanics demonstrates that proper setting of the APRV mode is crucial (<xref ref-type="bibr" rid="ref13">13</xref>). <bold>II</bold>&#x2014;<bold>(A)</bold> Photomicrographs of subpleural alveoli were recorded using <italic>in vivo</italic> microscopy during both inspiration and expiration. Black-and-white photographs of subpleural alveoli were captured with the <italic>in vivo</italic> microscope at <italic>inspiration</italic> and <italic>expiration</italic>. Individual alveoli are circled and color-coded in yellow, while collapsed alveoli are marked in red, using computer image analysis. The effects of APRV with two expiratory times (10 and 75%) and VCV with a low V<sub>T</sub> (6&#x202F;mL/kg) and two positive end-expiratory pressure (PEEP) levels (5 and 16 cmH<sub>2</sub>O) on alveolar recruitment and collapse were measured. For APRV, the expiratory time was determined using the equation F<sub>PE</sub> x 0.10 or 0.75&#x202F;=&#x202F;F<sub>EE</sub>. Two additional groups using 0.50 and 0.25 cofactors to determine the expiratory time with APRV were also investigated (data not shown). The difference in the number of alveoli (yellow) between inspiration and expiration directly reflects repetitive alveolar collapse and expansion (RACE), which is the mechanism of atelectrauma. <bold>(B)</bold> The numerical difference between the volume of open alveoli in the microscopic field during inspiration and expiration <bold>(A)</bold> was used to calculate RACE. The difference in the area of the photomicrograph occupied by alveoli during inspiration (light gray bar) and expiration (dark gray bars) indicates the level of alveolar instability (RACE). VCV with PEEP 5 did not recruit alveoli during inspiration nor prevent collapse during expiration, resulting in a high RACE level. PEEP 16 moderately increased recruitment while minimizing RACE. Both APRV groups had prolonged inspiratory time (T<sub>High</sub>), resulting in significant alveolar recruitment. Increasing expiratory time (T<sub>Low</sub>) (APRV 10%) caused substantial alveolar collapse at expiration, resulting in more RACE than PEEP 5. APRV 75% was the only strategy that opened and stabilized the alveoli, thereby preventing RACE and reducing stress multiplication. % of Photomicrograph, the percent of the photomicrograph covered by inflated alveoli (color coded yellow) (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g005.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel I illustrates the respiratory structure showing respiratory bronchioles, alveolar ducts, sacs, and alveoli during inspiration and expiration. Microscopic images contrast control and various PEEP and APRV levels. Panel II presents in vivo alveolar images paired with diagrams showing alveolar occupancy in different ventilation conditions. A bar graph compares alveolar occupancy percentages during inspiration and expiration across PEEP and APRV settings.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec21">
<title>Future research opportunities</title>
<p>Investigate alternative methods to determine T<sub>Low</sub> beyond using expiratory flow magnitude alone. These methods might allow P<sub>Low</sub> to exceed 0 cmH<sub>2</sub>O without compromising the primary benefits of APRV, provided that CO<sub>2</sub> retention and mucus clearance are not adversely affected.</p>
</sec>
</sec>
<sec id="sec22">
<title>Question 3: what is the optimal method for setting T<sub>High</sub>?</title>
<sec id="sec23">
<title>Background</title>
<p>Alveolar RD is a dynamic process influenced by both time and pressure. When increased pressure is applied to a derecruited lung, alveolar units gradually open even if the pressure remains constant (<xref ref-type="bibr" rid="ref53">53</xref>). In specific lung injuries characterized by slow recruitment kinetics, this process may persist throughout the entire T<sub>High</sub> and across multiple consecutive breaths. Although the volume of lung recruited during a single T<sub>High</sub> block may be small, the overall effect across multiple breaths can be significant, provided derecruitment is avoided during each T<sub>Low</sub>. Therefore, using a prolonged T<sub>High</sub> while still achieving sufficient expired minute volume (MVe), combined with a brief T<sub>Low</sub> set according to <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, can effectively gradually &#x2018;ratchet&#x2019; open atelectatic lung regions that do not respond to conventional PEEP strategies (<xref ref-type="bibr" rid="ref49">49</xref>). However, increasing T<sub>High</sub> lowers the respiratory rate (RR) and, consequently, reduces MVe. Although an intuitive misconception to increase MVe is to increase the T<sub>Low</sub> thereby increasing V<sub>T</sub>. However, this increases the risk of RACE-induced atelectrauma and should be avoided. This is explained below in the recommendations for the T<sub>Low</sub> setting. The more appropriate method is to decrease T<sub>High</sub> transiently to increase RR and MVe. Although this might slow lung recruitment, it will prevent RACE-induced VILI. As the lung is progressively &#x2018;ratcheted&#x2019; open, gas exchange improves, and the T<sub>High</sub> can be gradually increased.</p>
<p>The appropriate T<sub>High</sub> should be customized according to the severity of lung dysfunction and adjusted based on the patient&#x2019;s ventilatory efficiency to achieve normocapnia as lung function improves. Initially, T<sub>Hgh</sub> is set to ensure adequate bulk (convective) ventilation and MVe, particularly in patients with severe lung injury who require a higher RR. The T<sub>High</sub> is the rate controller in APRV and is similar to increasing the RR in conventional ventilation.</p>
<p>For example, in patients with established ARDS and hypercapnia transitioning to APRV, an initial T<sub>High</sub> of 1&#x2013;2&#x202F;s is typically used, yielding an RR of approximately 24&#x2013;35 breaths per minute. In this setup, a brief T<sub>High</sub> is combined with a brief T<sub>Low</sub> to keep the fraction of F<sub>EE</sub> at 75% of F<sub>PE</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>), thereby maintaining functional EELV and normalizing lung E<sub>RS</sub>. This creates a respiratory cycle characterized primarily by inspiration (<xref ref-type="fig" rid="fig2">Figure 2</xref>, CPAP Phase).</p>
<p>The T<sub>High</sub> controls convective and diffusive ventilation and also regulates end-inspiratory lung volume by recruiting additional alveoli with each breath, due to the time-dependent nature of recruitment (<xref ref-type="fig" rid="fig6">Figure 6</xref>) (<xref ref-type="bibr" rid="ref35">35</xref>). Reopening the lung increases the surface area for gas exchange, thereby improving CO<sub>2</sub> clearance through diffusive ventilation. Reopening also reduces local stress concentrators in the tissue (<xref ref-type="supplementary-material" rid="SM3">Supplementary File 3, Figure S2</xref>), thereby eliminating a significant mechanism of VILI (<xref ref-type="bibr" rid="ref11 ref12 ref13">11&#x2013;13</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Time- and pressure-dependent alveolar recruitment. In a rat model of Tween lavage-induced ARDS, subpleural alveolar and overall lung recruitment were measured at three static pressures (20, 30, and 40 cmH<sub>2</sub>O) held for 40&#x202F;s. The percentage of recruited subpleural alveoli in the microscopic field (black circles) and the gross lung recruitment on the lung surface, indicated by red atelectatic tissue (black lines) turning pink, were analyzed using computer image analysis. A time lag of approximately 2&#x202F;s, reflecting viscoelastic response, was observed between pressure application and the onset of recruitment. This was followed by rapid recruitment, then by gradual, continuous recruitment throughout the 40-s inflation period, indicating viscoelastic behavior. The airway pressure level also influenced recruitment (data not shown). These viscoelastic recruitment patterns were accurately predicted by a mathematical model that incorporated the effects of airway pressure and time. This study demonstrated that lung tissue can be recruited by extending the inspiratory time without additional mechanical power or energy cost.</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g006.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">A line graph shows percent recruitment over time, comparing gross and microscopic measurements at forty centimeters of water. Both lines rise quickly between zero and two seconds, then level off. Three lung images with microscopic views at zero, two, and forty seconds illustrate the recruitment process. The microscopic images are highlighted with outlined regions, showing changes in structure over time.</alt-text>
</graphic>
</fig>
<p>In contrast, for stable patients recovering from ARDS or receiving APRV as a preventive or lung-protective strategy, a longer initial T<sub>High</sub> (e.g., 4&#x2013;6&#x202F;s) may be used. This approach reduces RR and MVe; however, because most of the lung remains open, there is sufficient diffusion surface area to maintain normal PaCO<sub>2</sub>.</p>
<p>Although permissive hypercapnia may be acceptable in selected cases at the clinician&#x2019;s discretion, inducing hypercapnia is not a goal of APRV. Reports of hypercapnia in the literature are most commonly attributable to an excessively prolonged T<sub>High,</sub> particularly when ventilator settings are not appropriately adjusted to the degree of lung dysfunction during the early transition phase. Accordingly, initial APRV parameters should not be selected to target hypercapnia or to employ a prolonged T<sub>High</sub> that reduces MVe relative to prior ventilator settings. Instead, the primary objective is to maintain normocapnia with adequate MVe, even when the initial T<sub>High</sub> is brief&#x2014;though still approximately twice the duration of conventional inspiratory times. Lung reopening is initiated within this time frame.</p>
<p>As a patient&#x2019;s ventilatory efficiency improves, T<sub>High</sub> can be gradually increased. This adjustment is usually guided by trends toward normocapnic or even hypocapnic, which indicate effective CO&#x2082; removal. Increasing T<sub>High</sub> shifts ventilation from mainly convective, RR-driven mechanisms to a combination of convective and diffusive processes. This transition allows for significant reductions in both RR and MVe without compromising overall ventilation.</p>
</sec>
<sec id="sec24">
<title>Summary of basic science evidence</title>
<p>The recruitment of alveolar lung tissue at three different airway pressures over time was measured using a rat ARDS model (<xref ref-type="fig" rid="fig6">Figure 6</xref>) (<xref ref-type="bibr" rid="ref35">35</xref>). Gross lung recruitment was assessed by imaging the lung surface and calculating the recruitment rate (the proportion of red tissue that turned pink). Alveolar recruitment was evaluated using <italic>in vivo</italic> microscopy, and the proportion of the microscopic field occupied by alveoli was quantified by computer image analysis. Rapid recruitment occurred within the first 2&#x202F;s, followed by gradual recruitment over the next 40&#x202F;s. The results were accurately predicted by a mathematical model that incorporated both time and pressure. Extending the T<sub>High</sub> will continuously recruit lung tissue without additional mechanical power or &#x0394;P costs (<xref ref-type="bibr" rid="ref35">35</xref>).</p>
</sec>
<sec id="sec25">
<title>Recommendation</title>
<p>A T<sub>High</sub> of 4&#x2013;6&#x202F;s is typical for patients with routine post-operative atelectasis or normal lungs, but it may be too long when used as a rescue strategy for patients in respiratory failure. In these cases, a brief T<sub>High</sub> of 2&#x2013;3&#x202F;s may be necessary to increase MVe until the lung has recruited enough to exchange an adequate volume of CO<sub>2</sub>. This may not occur for 12&#x2013;24&#x202F;h, or even 24&#x2013;48&#x202F;h in lungs with severe ARDS (<xref ref-type="fig" rid="fig7">Figure 7</xref>) (<xref ref-type="bibr" rid="ref54">54</xref>).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>A 35-year-old man with catastrophic antiphospholipid syndrome and respiratory failure. <bold>(A)</bold> ARDSnet low tidal volume ventilation with pressure&#x2013;control assist&#x2013;control (PC-AC) mode, day 21, with extracorporeal membrane oxygenation (ECMO), day 15, and <bold>(B)</bold> day 36 on PC-AC with ECMO,. Transitioned to APRV on day 36. <bold>(C)</bold> 2 days on APRV, the lungs opened (clearer chest X-rays), and arterial blood gases (ABGs) improved. <bold>(D)</bold> After 11 days on APRV, the chest X-ray was clear, the ABGs normalized, and the patient was removed from ECMO and mechanical ventilation (<xref ref-type="bibr" rid="ref54">54</xref>). This case demonstrates the gradual &#x2018;ratcheting&#x2019; open of the lung tissue over several days with the use of the APRV (<xref ref-type="bibr" rid="ref49">49</xref>).</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g007.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Four chest X-rays comparing different days of ECMO and ventilation types. Panel A: ECMO Day 15, PC-AC Day 21, pH 7.35, pO&#x2082; 59, pCO&#x2082; 47, PaO&#x2082;/FiO&#x2082; 196. Panel B: ECMO Day 30, PC-AC Day 36, pH 7.32, pO&#x2082; 52, pCO&#x2082; 48, PaO&#x2082;/FiO&#x2082; 75. Panel C: ECMO Day 32, APRV Day 2, pH 7.43, pO&#x2082; 110, pCO&#x2082; 36, PaO&#x2082;/FiO&#x2082; 275. Panel D: ECMO Day 39, APRV Day 11, pH 7.37, pO&#x2082; 107, pCO&#x2082; 44, PaO&#x2082;/FiO&#x2082; 414.</alt-text>
</graphic>
</fig>
<p>Note that if V<sub>T</sub> falls below 3&#x202F;mL/kg of ideal body weight after switching from conventional ventilation to APRV, it may be necessary to lower T<sub>High</sub> and raise P<sub>High</sub> to maintain or exceed the pre-transition MVe. When switching from another ventilation mode, set T<sub>High</sub> to match the previous RR using the formula: 60/RR &#x2013; T<sub>Low</sub>&#x202F;=&#x202F;T<sub>High</sub>.</p>
<p>For example, with an RR of 26 during conventional ventilation and a T<sub>Low</sub> of 0.5&#x202F;s, the T<sub>High</sub> is 60/26&#x202F;=&#x202F;2.3&#x202F;s minus 0.5&#x202F;s (T<sub>Low</sub>), yielding 1.8&#x202F;s. When using APRV as the primary mode, set T<sub>High</sub> to 2&#x2013;4&#x202F;s for Mild ARDS, 2&#x2013;3&#x202F;s for Moderate ARDS, and 1&#x2013;3&#x202F;s for Severe ARDS. After obtaining blood gas results, T<sub>High</sub> can be adjusted up or down to maintain a normal PaCO<sub>2</sub>.</p>
</sec>
<sec id="sec26">
<title>Justifications and implementation considerations</title>
<p>When switching from conventional ventilation to APRV for a patient with severe ARDS, the T<sub>High</sub> should be brief to match the required conventional ventilation RR and MVe, ensuring that ventilation remains sufficient to maintain normocarbia. As the lung gradually recruits, the gas-exchange surface area increases, allowing T<sub>High</sub> to be extended to promote lung recruitment while maintaining normocarbia.</p>
</sec>
<sec id="sec27">
<title>Future research opportunities</title>
<p>Currently, the optimal combination of T<sub>High</sub> and P<sub>High</sub> for optimizing V<sub>T</sub> and MVe is determined empirically. Future work should focus on developing a computational approach to identify the optimal combination for each patient&#x2019;s lung condition, using techniques such as fuzzy logic.</p>
</sec>
</sec>
<sec id="sec28">
<title>Question 4: what is the optimal method for setting T<sub>Low</sub>?</title>
<sec id="sec29">
<title>Background</title>
<p>Personalizing T<sub>Low</sub> based on lung pathophysiology is essential for achieving lung-protective effects with APRV. T<sub>Low</sub> is adjusted using C<sub>RS</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>), which effectively prevents RACE. RACE causes tissue injury by over-distending open alveoli near collapsed lung regions and avoids harmful stresses on opposing epithelial walls during inflation (<xref ref-type="supplementary-material" rid="SM3">Supplementary File 3, Figure S3</xref>) (<xref ref-type="bibr" rid="ref55">55</xref>). Recently, we demonstrated in a pig model of surfactant deficiency that the energy dissipated in parenchymal tissues due to RACE correlates with outcomes (<xref ref-type="supplementary-material" rid="SM3">Supplementary File 3, Figure S5</xref>) (<xref ref-type="bibr" rid="ref56">56</xref>), and that alveolar collapse is more effectively prevented using a brief expiratory time combined with TC-PEEP than with the same set-PEEP and a longer expiratory duration (<xref ref-type="supplementary-material" rid="SM3">Supplementary File 3, Figure S9</xref>) (<xref ref-type="bibr" rid="ref5">5</xref>). When T<sub>Low</sub> is set using <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, it prevents progressive EELV loss and steers the lung away from the VILI Vortex (<xref ref-type="bibr" rid="ref37">37</xref>).</p>
<p>The T<sub>Low</sub> influences V<sub>T</sub>, which is affected by changes in C<sub>RS</sub>. A low C<sub>RS</sub>, common in <italic>Severe ARDS</italic>, results in a brief T<sub>Low</sub> when using the TCAV method. This reduces the amount of gas that escapes during exhalation, often resulting in a V<sub>T</sub> below 6&#x202F;mL/kg. As the lung heals and C<sub>RS</sub> increases, both T<sub>Low</sub> and V<sub>T</sub> also increase (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Therefore, when correctly set, APRV will not deliver dangerously large V<sub>T</sub> into a severely injured lung because it adjusts with changes in C<sub>RS</sub>, keeping &#x0394;P (V<sub>T</sub>/C<sub>RS</sub>) within safe limits (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
</sec>
<sec id="sec30">
<title>Summary of basic science evidence</title>
<p>The T<sub>Low</sub> controls V<sub>T</sub> and EELV, and therefore the level of TC-PEEP (<xref ref-type="fig" rid="fig3">Figure 3</xref>). After expiration begins, expiratory flow quickly reaches its peak value, F<sub>PE</sub>, then decreases progressively. The rate of decrease depends on the mechanical properties of the lungs, which change with acute lung injury, and remains approximately constant during the brief period defined by T<sub>Low</sub>. This means that T<sub>Low</sub> can be calculated from the expiratory flow curve, assuming it is a straight line, by identifying the point at which flow reaches 75% of F<sub>PE</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>).</p>
<p>During the Release Phase (P<sub>Low</sub>/T<sub>Low</sub>) (<xref ref-type="fig" rid="fig2">Figure 2</xref>), gas flow decreases at an approximately steady rate, reflecting the mechanical properties of the respiratory system. Since the duration of the Release Phase is calculated as F<sub>PE</sub>&#x202F;&#x00D7;&#x202F;75%&#x202F;=&#x202F;F<sub>EE</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>), the T<sub>Low</sub> is customized to the patient&#x2019;s respiratory mechanics&#x2019; timeline (<xref ref-type="fig" rid="fig3">Figure 3</xref>). This strategy has been validated clinically (<xref ref-type="fig" rid="fig7">Figure 7</xref>) and experimentally (<xref ref-type="fig" rid="fig5">Figure 5</xref>) to optimize alveolar stability, meaning it prevents alveolar collapse during exhalation and reinflation during inhalation (atelectrauma) (<xref ref-type="bibr" rid="ref11 ref12 ref13">11&#x2013;13</xref>, <xref ref-type="bibr" rid="ref40">40</xref>, <xref ref-type="bibr" rid="ref41">41</xref>, <xref ref-type="bibr" rid="ref57">57</xref>).</p>
<p>The T<sub>Low</sub> is the key parameter that personalizes APRV settings based on lung pathophysiology and regulates V<sub>T</sub>, TC-PEEP, and EELV (<xref ref-type="fig" rid="fig8">Figure 8</xref>). The Slope<sub>EF</sub> is a breath-by-breath measure of C<sub>RS</sub>. A decrease in C<sub>RS</sub> increases expiratory flow rate, resulting in a steeper slope and a more rapid attainment of the calculated F<sub>EE</sub> (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>), thereby shortening T<sub>Low</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>). <xref ref-type="fig" rid="fig8">Figure 8</xref> illustrates the relationship between C<sub>RS</sub>, T<sub>Low</sub>, and Slope<sub>EF</sub>.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>The relationship between changes in respiratory system compliance (CRS) and expiratory time (T<sub>Low</sub>, grey) during airway pressure release ventilation (APRV) is shown. This coupling occurs when T<sub>Low</sub> is set as a fraction (75%) of the peak expiratory flow (Fig. 2); the lower the CRS, the briefer the T<sub>Low</sub>. Increasing intra-abdominal pressure (IAP) causes a gradual decrease in CRS. The slope of the expiratory flow curve (Slope<sub>EF</sub>, red) is a breath-by-breath measure of CRS using a method similar to spirometry. The expiratory time needed to reach zero expiratory flow and pressure (T<sub>Exp</sub>, black) is compared with the T<sub>Low</sub> setting (T<sub>Low</sub>, grey). Note that the T<sub>Low</sub> is set to terminate before the expiratory flow and pressure reaches zero. <bold>(A)</bold> Normal Lung: As CRS decreases with increased IAP, the Slope<sub>EF</sub> (red) also decreases. This leads to a progressive reduction in T<sub>Low</sub> from 0.51 seconds at an IAP of 0 mmHg to 0.46 seconds at an IAP of 15 mmHg. <bold>(B)</bold> Tween-Injured Lung: The same relationship between changes in CRS (i.e.,Slope<sub>EF</sub>) and the T<sub>Low</sub> is observed in the acutely injured lung with surfactant deactivation by Tween lavage. As IAP is increased to reduce CRS, T<sub>Low</sub> decreases from 0.44 seconds at an IAP of 0 mmHg to 0.34 seconds at an IAP of 15 mmHg (<xref ref-type="bibr" rid="ref37">37</xref>). Note that T<sub>Low</sub> is consistently lower in the acutely injured lung at each level of IAP.</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g008.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Two side-by-side bar charts compare normal and tween-injured lungs. Both charts show intra-abdominal insufflation pressure in millimeters of mercury on the x-axis and time in seconds and slope on the y-axes. The left chart (normal lung) indicates a decrease in time and slope with increased pressure. The right chart (tween-injured lung) shows a similar trend. Bars represent TExp and TLow values, and a red line with circles depicts the slope. Green-dotted shapes highlight schematic illustrations above each chart.</alt-text>
</graphic>
</fig>
<p>Substantial experimental evidence supports the idea that effectively using expiratory time stabilizes alveoli (<xref ref-type="fig" rid="fig5">Figure 5</xref>) (<xref ref-type="bibr" rid="ref11 ref12 ref13">11&#x2013;13</xref>), preventing RACE-induced energy dissipation (<xref ref-type="supplementary-material" rid="SM3">Supplementary File 3, Figure S5, S6</xref>) and tissue damage (<xref ref-type="fig" rid="fig4">Figure 4</xref>) (<xref ref-type="bibr" rid="ref5">5</xref>). In a clinically relevant 48-h porcine model of peritoneal sepsis and gut ischemia/reperfusion, personalized T<sub>Low</sub>, along with the other recommended parameters, offered significant lung protection (<xref ref-type="fig" rid="fig4">Figure 4</xref>) (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref50">50</xref>, <xref ref-type="bibr" rid="ref58">58</xref>). We showed that personalized T<sub>Low</sub> prevents EELV loss, maintains normal C<sub>RS</sub> and &#x0394;P even with a V<sub>T</sub> of 12&#x202F;mL/kg (<xref ref-type="bibr" rid="ref28">28</xref>). When T<sub>Low</sub> is set using <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, together with the three other recommended settings, it progressively increases C<sub>RS</sub> while maintaining &#x0394;P within the safe range (&#x0394;P&#x202F;=&#x202F;V<sub>T</sub>/C<sub>RS</sub>) (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p>
<p>Histologic analysis of alveoli and alveolar ducts during inspiration and expiration (<xref ref-type="fig" rid="fig5">Figure 5</xref>, I) (<xref ref-type="bibr" rid="ref13">13</xref>), along with direct observation of subpleural alveoli using <italic>in vivo</italic> microscopy (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>), highlights the critical role of personalized T<sub>Low</sub> in lung stability (alveoli and ducts) (<xref ref-type="fig" rid="fig5">Figure 5</xref>, II). Using computational models, we confirmed the influence of time on alveolar recruitment and stabilization, as shown in animal studies (<xref ref-type="bibr" rid="ref29 ref30 ref31 ref32 ref33">29&#x2013;33</xref>), along with computational validation of the biological data (<xref ref-type="supplementary-material" rid="SM6">Supplementary File 6</xref>) (<xref ref-type="bibr" rid="ref35">35</xref>, <xref ref-type="bibr" rid="ref36">36</xref>).</p>
<p>The relationship between T<sub>Low</sub>, C<sub>RS</sub>, and Slope<sub>EF</sub> was examined in a recent study (<xref ref-type="fig" rid="fig8">Figure 8</xref>) (<xref ref-type="bibr" rid="ref14">14</xref>). The study used normal pigs and a Tween-induced surfactant deactivation ARDS model. The C<sub>CW</sub> was decreased by peritoneal CO<sub>2</sub> insufflation to elevate abdominal pressures (0, 6, 8, 10, 12, 14, 15&#x202F;mmHg). The T<sub>Low</sub>, Slope<sub>EF</sub> (liters/s<sup>2</sup>), EELV, and the time to reach complete expiration to functional residual capacity (T<sub>Exp</sub>) were measured at each level of C<sub>CW</sub>.</p>
<p>As C<sub>RS</sub> decreased with increasing intra-abdominal pressure, T<sub>Low</sub>, T<sub>Exp</sub>, and Slope<sub>EF</sub> all progressively declined in both normal and Tween-injured (ARDS model) lungs (<xref ref-type="fig" rid="fig8">Figure 8</xref>). This study demonstrates the interconnected relationship between T<sub>Low</sub>, T<sub>Exp</sub>, and Slope<sub>EF</sub>, and how T<sub>Low</sub> is coupled with C<sub>RS</sub>, which Slope<sub>EF</sub> measures on a breath-by-breath basis. Changes in the Slope<sub>EF</sub> can also be used to detect worsening lung injury and estimate EELV (<xref ref-type="bibr" rid="ref14">14</xref>).</p>
<p>The clinician adjusts T<sub>Low</sub> until the calculated F<sub>EE</sub> is achieved (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>). For example, if F<sub>PE</sub> is 60&#x202F;L/min, then F<sub>EE</sub> would be 60 &#x00D7; 75%&#x202F;=&#x202F;45&#x202F;L/min, so the clinician adjusts T<sub>Low</sub> so that the next expiration begins when F<sub>EE</sub> reaches 45&#x202F;L/min (<xref ref-type="fig" rid="fig3">Figure 3</xref>). A patient with mild lung injury shows a slight decrease in C<sub>RS</sub> along with a small increase in lung recoil and normal EELV (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Because gas exits the lung slowly, the Slope<sub>EF</sub> is gradual, and terminating expiration at F<sub>EE</sub>&#x202F;=&#x202F;45&#x202F;L/min, as calculated by <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, results in a T<sub>Low</sub> of 0.48&#x202F;s. Severe ARDS significantly reduces C<sub>RS</sub>, increases lung recoil, and decreases EELV (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). High lung recoil quickly expels gas, creating a steep Slope<sub>EF</sub> so that the same F<sub>EE</sub> (&#x2212;45&#x202F;L/min) results in a T<sub>Low</sub> of only 0.38&#x202F;s. As mentioned earlier, T<sub>Low</sub> is guided by changes in C<sub>RS</sub>.</p>
<p>Setting T<sub>Low</sub> using <xref ref-type="disp-formula" rid="E1">Equation 1</xref> typically yields a V<sub>T</sub>&#x202F;&#x003C;&#x202F;6&#x202F;mL/kg in a severely injured lung (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This occurs because V<sub>T</sub> and C<sub>RS</sub> are coupled, and this relationship varies with Slope<sub>EF</sub> angle (Low C<sub>RS</sub>&#x202F;=&#x202F;low V<sub>T</sub> and vice versa). In cases of mild lung injury with relatively normal C<sub>RS</sub> and EELV, a shallower Slope<sub>EF</sub> results in an increase in T<sub>Low</sub>. This leads to greater Release Gas Volume (V<sub>R</sub>) and lung pressure, resulting in a relatively high V<sub>T</sub> (&#x003E;6&#x202F;mL/kg) and a lower TC-PEEP (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p>
<p>In contrast, severe ARDS, characterized by low C<sub>RS</sub> and EELV, increases lung recoil, leading to a steeper Slope<sub>EF</sub> and a significant reduction in T<sub>Low</sub>. This decreased V<sub>R</sub> requires a similar small V<sub>T</sub> during inflation (&#x003C;6&#x202F;mL/kg) while increasing TC-PEEP (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). At the end of a 48-h porcine model of peritoneal sepsis and gut ischemia/reperfusion (PS&#x202F;+&#x202F;I/R)-induced ARDS, the APRV group, with settings similar to those recommended in this consensus conference, had a V<sub>T</sub> of 12&#x202F;mL/kg and C<sub>RS</sub> of 42&#x202F;mL/cmH<sub>2</sub>O, compared to the LV<sub>T</sub> group with a V<sub>T</sub> of 5.8&#x202F;mL/kg and C<sub>RS</sub> of 9&#x202F;mL/cmH<sub>2</sub>O. Even with a V<sub>T</sub> of 12&#x202F;mL/kg&#x2014;believed to cause VILI&#x2014;the APRV group maintained a safe &#x0394;P because of the high C<sub>RS</sub> (&#x0394;P&#x202F;=&#x202F;V<sub>T</sub>/C<sub>RS</sub>) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Therefore, it is not just the size of the delivered V<sub>T</sub> that causes injury, but also the volume and lung pathophysiology into which it is introduced that determine whether a mechanical breath is harmful or protective.</p>
</sec>
<sec id="sec31">
<title>Recommendation</title>
<p>When switching from another ventilation mode, initially set T<sub>Low</sub> to 0.3&#x2013;0.6&#x202F;s. When starting with ARPV for Mild ARDS, use 0.4&#x2013;0.6&#x202F;s; for Moderate ARDS, use 0.3&#x2013;0.5&#x202F;s; and for Severe ARDS, use 0.2&#x2013;0.3&#x202F;s.</p>
<p>Once the patient stabilizes, T<sub>Low</sub> is customized based on the Slope<sub>EF</sub> of the expiratory flow waveform (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>). <xref ref-type="fig" rid="fig9">Figure 9</xref> shows the clinician&#x2019;s observation when T<sub>Low</sub> is calculated and set according to <xref ref-type="disp-formula" rid="E1">Equation 1</xref>. In this example, F<sub>PE</sub> is approximately 75&#x202F;L/min. Therefore, using <xref ref-type="disp-formula" rid="E1">Equation 1</xref> (F<sub>PE</sub> 75&#x202F;L/min x 75%&#x202F;=&#x202F;F<sub>EE</sub> 56&#x202F;L/min), the clinician should adjust T<sub>Low</sub> until the calculated F<sub>EE</sub> (56&#x202F;L/min) is reached (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Thus, the clinician does not set T<sub>Low</sub> to a specific time but instead to reach the calculated F<sub>EE</sub>. The time taken for the lung to empty from F<sub>PE</sub> to F<sub>EE</sub> represents the desired T<sub>Low</sub> (<xref ref-type="fig" rid="fig9">Figure 9</xref>, red bracket). Ideally, T<sub>Low</sub> is fine-tuned in 0.01-s steps for precise control. If V<sub>T</sub> is decreased, thereby decreasing MVe, the T<sub>Low</sub> should not be increased beyond 75% to achieve MVe to increase V<sub>T</sub> or improve CO<sub>2</sub> removal as this has been shown to increase the risk of RACE-induced atelectrauma (<xref ref-type="bibr" rid="ref41">41</xref>).</p>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption>
<p>Setting expiratory time (T<sub>Low</sub>) as shown on a ventilator monitor. The peak expiratory flow (F<sub>PE</sub>) is identified and, in this example, measures ~75&#x202F;L/min. <xref ref-type="disp-formula" rid="E1">Equation 1</xref> is used to calculate the end expiratory flow (F<sub>EE</sub>) (F<sub>PE</sub> 75&#x202F;L/min x 75%&#x202F;=&#x202F;F<sub>EE</sub> 56&#x202F;L/min), at which point expiratory flow will be terminated and the lung reinflated. The T<sub>Low</sub> is adjusted (red controller and line) to terminate at 56&#x202F;L/min, which occurs at 0.5&#x202F;s. The T<sub>Low</sub> dial is not adjusted to a specific time but rather to end expiratory flow and reinflate the lung at the calculated value (56&#x202F;L/min). If the T<sub>Low</sub> set initially does not reach the calculated F<sub>EE</sub> target, it will be adjusted upward or downward until it does (<xref ref-type="bibr" rid="ref65">65</xref>).</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g009.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Ventilator screen displaying a pressure control airway pressure release ventilation (PC-APRV) waveform. The graph includes pressure, flow, and CO2 levels over time. Key parameters are highlighted: PIP at 35 cmH2O, Pmean at 31 cmH2O, tidal volume at 452 mL, minute volume at 4.62 L/min, FiO2 at 60%, and end-tidal CO2 at 6.1 kPa. A formula shows \(F_{PE} \times 0.75 = F_{EE}\). Settings below include FiO2 at 60, Slope 0.00, Phigh 30, Plow 0.0, Thigh 5.00, and Tlow 0.50.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec32">
<title>Justifications and implementation considerations</title>
<p>Histological analysis of a rat ARDS model, with lungs fixed at inspiration and expiration, showed that the T<sub>Low</sub> set, using <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, effectively distributes gas throughout the alveoli and ducts, closely resembling normal lung function (<xref ref-type="fig" rid="fig5">Figure 5</xref>, I). In contrast, T<sub>Low</sub> determined using the equation F<sub>PE</sub> x 10%&#x202F;=&#x202F;F<sub>EE</sub> (APRV 10%) extends T<sub>Low</sub>, leading to overdistension of the alveolar ducts (<xref ref-type="fig" rid="fig5">Figure 5</xref>, I). Direct <italic>in vivo</italic> visualization of subpleural alveoli revealed that the T<sub>Low</sub> set using <xref ref-type="disp-formula" rid="E1">Equation 1</xref> was the most effective in recruiting and stabilizing alveoli. The APRV 10% group successfully recruited alveoli during inspiration with the extended T<sub>High</sub> but failed to prevent collapse during exhalation, resulting in RACE (<xref ref-type="fig" rid="fig5">Figure 5</xref>, II). Using the same methodology, it was shown that T<sub>Low</sub> set with <xref ref-type="disp-formula" rid="E1">Equation 1</xref> was most effective in achieving uniform alveolar behavior compared to T<sub>Low</sub> set with the following cofactors: F<sub>PE</sub> x 10, 25, 50%&#x202F;=&#x202F;F<sub>EE</sub> (<xref ref-type="bibr" rid="ref11">11</xref>).</p>
<p>Three studies using a clinically relevant 48-h porcine PS&#x202F;+&#x202F;I/R ARDS model showed that setting T<sub>Low</sub> based on <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, along with three other consensus conference-recommended settings, provided significant lung protection (<xref ref-type="fig" rid="fig4">Figure 4</xref>) (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref50">50</xref>, <xref ref-type="bibr" rid="ref58">58</xref>). Additionally, case studies (<xref ref-type="fig" rid="fig7">Figure 7</xref>) (<xref ref-type="bibr" rid="ref59">59</xref>, <xref ref-type="bibr" rid="ref60">60</xref>) and a statistical comparison involving ICU patients (<xref ref-type="fig" rid="fig10">Figure 10</xref>) (<xref ref-type="bibr" rid="ref57">57</xref>) suggest that the T<sub>Low</sub> set, as defined by <xref ref-type="disp-formula" rid="E1">Equation 1</xref>, in combination with the three other recommended settings, provides significant lung protection.</p>
<fig position="float" id="fig10">
<label>Figure 10</label>
<caption>
<p>A systematic review was conducted comparing conventional ventilation (bar and whisker) in 16 intensive care units (ICUs) with airway pressure release ventilation (APRV) set and adjusted using the time-controlled adaptive ventilation (TCAV) method at the R Adams Cowley Shock Trauma Center (red dots). The TCAV patients were in the upper quartile for the Injury Severity Score (ISS), demonstrating severe injury. The percentage of patients on TCAV who developed ARDS (ARDS%) during their hospital stay was below the lower quartile (red dot). The Lung Injury Prediction Score (LIPS) in the TCAV group was 8.7, indicating that the ARDS incidence (ARDS%) should be 35%. However, the incidence of ARDS compared with the 16 other ICUs was 1.3% vs. 14.0%, and in-hospital ARDS mortality was 3.9% vs. 14.1%, using the TCAV method. This demonstrates that TCAV, when applied early, can reduce the incidence and mortality associated with ARDS.</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g010.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Box plots labeled A, B, and C show data distributions. A represents Overall Mean ISS with median around 26. B shows ARDS percentages with median near 17. C illustrates In Hospital Mortality percentages with median approximately 10. Each plot has min, max, and quartile values indicated.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec33">
<title>Future research opportunities</title>
<p>Extensive scientific and clinical evidence support using the recommended <xref ref-type="disp-formula" rid="E1">Equation 1</xref> to set T<sub>Low</sub> when employing the APRV mode (<xref ref-type="supplementary-material" rid="SM3">Supplementary Files 3&#x2013;7</xref>). Of the four APRV parameters, the recommendations for setting T<sub>Low</sub> and P<sub>Low</sub> have the most published scientific backing (<xref ref-type="supplementary-material" rid="SM2">Supplementary File 2</xref>). Future work to refine T<sub>High</sub> and P<sub>High</sub> settings, potentially through computational modeling and fuzzy logic, could help maximize APRV&#x2019;s lung-protective capabilities.</p>
</sec>
</sec>
</sec>
</sec>
<sec id="sec34">
<title>Recommendation protocol</title>
<p>As defined by the Berlin criteria, ARDS is a form of acute, diffuse, inflammatory lung injury characterized by the rapid onset of respiratory failure within one week of a known clinical insult or new/worsening symptoms. The severity of ARDS is classified based on the degree of hypoxemia, measured by the PaO&#x2082;/FiO&#x2082; ratio, with a minimum requirement of 5&#x202F;cm H&#x2082;O positive end expiratory pressure (PEEP): mild (200&#x2013;300&#x202F;mmHg), moderate (100&#x2013;200&#x202F;mmHg), and severe (&#x003C;100&#x202F;mmHg) (<xref ref-type="bibr" rid="ref9">9</xref>).</p>
<p>The committee&#x2019;s recommendation <italic>Protocol</italic> is as follows:</p>
<p>Stepwise approach for <italic>initial</italic> APRV settings:<list list-type="alpha-lower">
<list-item>
<p>P<sub>High</sub></p>
<list list-type="roman-lower">
<list-item>
<p>Transitioning from conventional mode:</p>
<list list-type="order">
<list-item>
<p>Volume Control (VC) mode: Use P<sub>Plat</sub> to set P<sub>High</sub> (Note: an inspiratory hold may be required if a P<sub>Plat</sub> is not measured with a brief inspiratory time)</p>
</list-item>
<list-item>
<p>Pressure Control (PC) mode: Use PIP to set P<sub>High</sub></p>
</list-item>
<list-item>
<p>Dual Targeted (DT) mode&#x002A; (i.e., PRVC): The PIP is used to set P<sub>High</sub> when there is no spontaneous effort; however, if spontaneous efforts are vigorous and the set V<sub>T</sub> is exceeded, the PIP will be inaccurate and reflect the PEEP level. This is because these modes display negative proportionality [i.e., the greater the effort (pleural pressure), the lower the applied airway pressure] (Note: May consider changing to a VC or PC mode to obtain an accurate P<sub>Plat</sub> /PIP pressure, respectively)</p>
</list-item>
<list-item>
<p>High Frequency Oscillatory Ventilation (HFOV) mode: Use Paw plus 2&#x2013;4 cmH<sub>2</sub>O to set P<sub>High</sub></p>
</list-item>
</list>
</list-item>
<list-item>
<p>When APRV is the primary mode at the start of mechanical ventilation, recommendations for <italic>initial</italic> P<sub>High</sub> ranges:</p>
<list list-type="order">
<list-item>
<p>Mild ARDS: 20&#x2013;24 cmH<sub>2</sub>O</p>
</list-item>
<list-item>
<p>Moderate ARDS: 25&#x2013;29 cmH<sub>2</sub>O</p>
</list-item>
<list-item>
<p>Severe ARDS: 26&#x2013;30 cmH<sub>2</sub>O&#x2021;</p>
</list-item>
</list>
</list-item>
</list>
</list-item>
</list></p>
<p>Note: With decreased C<sub>RS</sub> or increased E<sub>RS</sub>, V<sub>T</sub> may be &#x003C;4&#x202F;mL/kg; in this case, P<sub>High</sub> may be increased in 2 cmH<sub>2</sub>O increments to achieve a minimum V<sub>T</sub> of 5&#x2013;6&#x202F;mL/kg.</p>
<p>&#x002A;Dual-targeted (DT) is a mode in which V<sub>T</sub> is set, and pressure is automatically regulated to limit airway pressure based on the measured exhaled V<sub>T</sub> from the previous breath<sub>.</sub> &#x2021;Depending on the patient&#x2019;s body type and chest wall compliance, a P<sub>High</sub> greater than 30 cmH<sub>2</sub>O may be needed.<list list-type="alpha-lower">
<list-item>
<p>T<sub>High</sub></p>
<list list-type="roman-lower">
<list-item>
<p>Transitioning from a conventional mode:</p>
<list list-type="order">
<list-item>
<p>Set initial T<sub>High</sub> to match RR on conventional mode to achieve desired MVe. This may be achieved by using the equation: 60/RR &#x2013; T<sub>Low</sub>. Example: 60/26&#x202F;=&#x202F;2.3&#x202F;s &#x2013; 0.5&#x202F;=&#x202F;T<sub>High</sub> 1.8&#x202F;s. The T<sub>High</sub> on APRV requires adjustment once the T<sub>Low</sub> is confirmed to match MVe from conventional mode. If respiratory acidosis is present on conventional mode, an even higher MVe may be needed and achieved by reducing the T<sub>High</sub> to increase RR. Note: With decreased C<sub>RS</sub> / increased E<sub>RS</sub>, V<sub>T</sub> may be &#x003C;4&#x202F;mL/kg; in this case, P<sub>High</sub> may be increased in 2 cmH<sub>2</sub>O increments to achieve a minimum V<sub>T</sub> of 5&#x2013;6&#x202F;mL/kg.</p>
</list-item>
</list>
</list-item>
<list-item>
<p>When APRV is the primary mode, set T<sub>High</sub> at:</p>
<list list-type="order">
<list-item>
<p>Mild ARDS: 2&#x2013;4&#x202F;s</p>
</list-item>
<list-item>
<p>Moderate ARDS: 2&#x2013;3&#x202F;s</p>
</list-item>
<list-item>
<p>Severe ARDS: 1.5&#x2013;3&#x202F;s. Note: Using a very brief T<sub>High</sub> (e.g., 1.5&#x202F;s) may be necessary to ensure adequate MVe to maintain normocapnia. Since it takes approximately 1.5&#x202F;s for the inspiratory airway pressure to reach the distal airspace, the inspiratory flow should be monitored to ensure it returns to baseline (i.e., reaches a no-flow state) (<xref ref-type="bibr" rid="ref10">10</xref>). If it does not return to baseline, the T<sub>High</sub> should be increased in small-millisecond steps to achieve this. For example, if a T<sub>High</sub> of 1.5&#x202F;s terminates the inspiratory flow and does not return to baseline, the T<sub>High</sub> may be increased by 0.1-s increments (i.e., 1.6&#x202F;s) and assessed to determine if the inspiratory flow reaches a no-flow state to prevent inspiratory flow starvation. Later, the T<sub>High</sub> may be gradually increased as PaCO<sub>2</sub> decreases<sub>,</sub> as more lung surface area becomes available for ventilation and stability is achieved over time.</p>
</list-item>
</list>
</list-item>
</list>
</list-item>
<list-item>
<p>P<sub>Low</sub></p>
<list list-type="roman-lower">
<list-item>
<p>P<sub>Low</sub> is set to 0 cmH<sub>2</sub>O when transitioning from another mode or when serving as the primary mode.</p>
</list-item>
</list>
</list-item>
<list-item>
<p>T<sub>Low</sub></p>
<list list-type="roman-lower">
<list-item>
<p>The T<sub>Low</sub> is initially set within the ranges listed below, based on lung pathophysiology, when transitioning from another mode or when used as the primary mode. After several breath cycles, once the waveform stabilizes, the T<sub>Low</sub> should be calculated. This is done by using the Slope<sub>EF</sub> and <xref ref-type="disp-formula" rid="E1">Equation 1</xref>. The T<sub>Low</sub> is determined from lung pathophysiology, as measured by Slope<sub>EF,</sub> when the P<sub>Low</sub> is set to 0 cmH<sub>2</sub>O. It is established to the fraction of F<sub>EE</sub> at 75% of the F<sub>PE</sub>. The T<sub>Low</sub> is adjusted until the target F<sub>EE</sub> is achieved, is personalized to lung pathophysiology, and reflects lung collapse time constants. For example, if F<sub>PE</sub>&#x202F;=&#x202F;60&#x202F;L/min, the clinician adjusts T<sub>Low</sub> until expiration ends when the flow is F<sub>PE</sub>&#x202F;=&#x202F;45&#x202F;L/min. [60&#x202F;L/min&#x202F;&#x00D7;&#x202F;75%&#x202F;=&#x202F;F<sub>EE</sub> 45&#x202F;L/min].</p>
</list-item>
<list-item>
<p>Initial T<sub>Low</sub> settings.</p>
<list list-type="order">
<list-item>
<p>The initial T<sub>Low</sub> should be based on lung pathophysiology whether APRV is set as the primary mode, or when transitioning from a conventional mode.</p>
<list list-type="alpha-lower">
<list-item>
<p>Normal lung physiology or post-operative respiratory failure: 0.4&#x2013;0.6&#x202F;s</p>
</list-item>
<list-item>
<p>Mild ARDS: 0.4&#x2013;0.6&#x202F;s</p>
</list-item>
<list-item>
<p>Moderate ARDS: 0.3&#x2013;0.5&#x202F;s</p>
</list-item>
<list-item>
<p>Severe ARDS: 0.2&#x2013;0.4&#x202F;s</p>
</list-item>
</list>
</list-item>
<list-item>
<p>Allow a 15&#x2013;30&#x202F;s cycle for the waveform to stabilize</p>
</list-item>
<list-item>
<p>Freeze the screen to analyze the waveform and measure F<sub>PE</sub></p>
</list-item>
<list-item>
<p>Scroll to the right to measure F<sub>EE</sub></p>
</list-item>
<list-item>
<p>Calculate F<sub>PE</sub>/F<sub>EE</sub></p>
</list-item>
<list-item>
<p>Adjust T<sub>Low</sub> as needed to obtain F<sub>PE</sub>/F<sub>EE</sub> at 75% (decrease T<sub>Low</sub> if &#x003C;75% or increase T<sub>Low</sub> if &#x003E;75%) (<xref ref-type="disp-formula" rid="E1">Equation 1</xref>).</p>
</list-item>
</list>
</list-item>
</list>
</list-item>
</list></p>
<sec id="sec35">
<title>Highlights and monitoring</title>
<p>
<list list-type="alpha-lower">
<list-item>
<p>The T<sub>Low</sub> should not be increased solely to obtain a higher V<sub>T</sub> or to improve PaCO<sub>2</sub>. If V<sub>T</sub>&#x202F;&#x003C;&#x202F;4&#x202F;mL/kg, increase P<sub>High</sub> to achieve a minimum of 5&#x2013;6&#x202F;mL/kg V<sub>T</sub>. A larger V<sub>T</sub> results from increasing T<sub>Low</sub> to terminate less than 75% of F<sub>PE,</sub> thereby increasing MVe and temporarily reducing PaCO<sub>2</sub>. However, extending the expiratory duration may lead to alveolar instability, allowing alveoli time to collapse and resulting in repetitive alveolar collapse and expansion (RACE)-induced atelectrauma (<xref ref-type="bibr" rid="ref11 ref12 ref13">11&#x2013;13</xref>). Ultimately, progressive loss of lung volume to collapse with improperly set T<sub>Low</sub> results in an increase in PaCO<sub>2</sub> as the area for diffusive gas exchange decreases. Although this may temporarily slow alveolar recruitment, adequate ventilation is balanced with progressive airway reopening; T<sub>Low</sub> cannot be increased since RACE must be prevented at all costs. If V<sub>T</sub> &#x003E;&#x202F;5&#x202F;mL/kg but MVe is less than on conventional ventilation, T<sub>High</sub> may be decreased to increase RR and achieve the necessary MVe. As PaCO<sub>2</sub> improves, T<sub>High</sub> can be progressively increased, thereby accelerating lung recruitment.</p>
</list-item>
<list-item>
<p>P<sub>Low</sub> should not be set above 0 cmH<sub>2</sub>O:</p>
<list list-type="roman-lower">
<list-item>
<p>Setting a P<sub>Low</sub> above 0 cmH<sub>2</sub>O alters the Slope<sub>EF,</sub> so it cannot be used as in spirometry to assess the severity of lung pathophysiology, which is essential for correctly setting T<sub>Low</sub>. The slope of passive exhalation reflects the elastic recoil of the respiratory system and is proportional to changes in elastance (E<sub>RS</sub>) (<xref ref-type="bibr" rid="ref14">14</xref>). For passive recoil to accurately represent respiratory system mechanics, the flow must not be obstructed by the added expiratory resistance of PEEP, as this alters the flow/time relationship during passive exhalation toward elastic equilibrium.</p>
</list-item>
<list-item>
<p>P<sub>Low</sub> &#x003C;&#x202F;0 cmH<sub>2</sub>O decreases expiratory flow rate, thereby reducing CO<sub>2</sub> removal and leading to hypercapnia.</p>
</list-item>
<list-item>
<p>Airway secretions are removed less effectively when P<sub>Low</sub> is set &#x003E; 0 cmH<sub>2</sub>O, increasing the risk of ventilator-associated pneumonia.</p>
</list-item>
</list>
</list-item>
<list-item>
<p>PS above P<sub>High</sub> is not recommended.</p>
<list list-type="roman-lower">
<list-item>
<p>During APRV, most spontaneous breaths occur during T<sub>High</sub> at the P<sub>High</sub> level, also called the continuous positive airway pressure (CPAP) phase. Usually, the patient&#x2019;s inspiratory effort&#x2014;primarily driven by diaphragmatic activity&#x2014;is self-limiting, thereby helping to prevent lung overinflation. However, applying PS above P<sub>High</sub> adds extra inspiratory pressure and volume during spontaneous breaths. This can significantly increase lung stress and strain, thereby increasing the risk of volutrauma and barotrauma, particularly in injured or heterogeneous lungs, such as in ARDS.</p>
</list-item>
<list-item>
<p>PS fundamentally changes the flow dynamics of spontaneous breathing. Without PS, spontaneous inspiratory flow typically follows a sinusoidal pattern, as in natural breathing. Adding PS shifts the flow pattern to a decelerating pattern, more similar to mechanically assisted ventilation than to unassisted spontaneous effort. This change may decrease patient comfort, disrupt normal diaphragmatic mechanics, and potentially impair patient&#x2013;ventilator synchrony.</p>
</list-item>
<list-item>
<p>Key clinical implication: To preserve physiological breathing patterns and minimize the risk of uncontrolled lung overdistension, PS should not be added above P<sub>High</sub> during APRV. Note: If automatic tube compensation is not available, a maximum PS of 2&#x2013;5 cmH<sub>2</sub>O may be used to overcome the resistive load of the artificial airway, with the understanding that during spontaneous breaths, the gas flow will be delivered in a decelerating manner, and this pressure will be added on top of P<sub>High.</sub></p>
</list-item>
</list>
</list-item>
<list-item>
<p>Monitoring:</p>
<list list-type="roman-lower">
<list-item>
<p>Changes in the C<sub>RS</sub> of the lung or chest wall may require adjustments. For instance, if C<sub>RS</sub> decreases or the patient is placed in the prone position, thereby reducing V<sub>T</sub>, an increase in P<sub>High</sub> may be necessary.</p>
</list-item>
<list-item>
<p>Assessment of waveforms should be made at a minimum every 6&#x202F;h.</p>
</list-item>
<list-item>
<p>Alarm limits for MVe and V<sub>T</sub> should be set appropriately to identify changes in C<sub>RS</sub>.</p>
</list-item>
<list-item>
<p>If there is an obstruction from secretions, water in the circuit, a wet expiratory filter, or a humidified moisture exchanger, the Slope<sub>EF</sub> will change from a 45-degree angle to a 90-degree angle, requiring troubleshooting such as suctioning, emptying water from the circuit, or changing wet filters.</p>
</list-item>
</list>
</list-item>
</list>
</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec36">
<title>Discussion</title>
<p>This manuscript represents an expert consensus and recommendation document rather than a formal clinical practice guideline. The consensus was developed to synthesize current physiologic principles, experimental data, and available clinical evidence related to APRV, in areas where definitive high-level evidence remains limited. While aspects of APRV are supported by preclinical studies, physiologic investigations, and observational or single-center clinical experiences, large multicenter randomized controlled trials evaluating patient-centered outcomes are currently lacking in several domains. Accordingly, the recommendations presented herein should be interpreted as guidance informed by expert interpretation of lung-protective physiology and the best available evidence, rather than prescriptive standards of care. This consensus aims to provide a structured, physiology-based framework to reduce practice variability, inform the safe and rational application of APRV, and serve as a foundation for future trials designed to more definitively define efficacy, patient selection, and optimal timing of initiation.</p>
<p>The faculty unanimously agreed on the four APRV settings, which closely align with those previously described for the time-controlled adaptive ventilation (TCAV) method. The recommended settings constitute a personalized, protocolized approach that continuously adapts to a patient&#x2019;s respiratory mechanics and partial pressure of carbon dioxide (PaCO&#x2082;). The brief time (T<sub>Low</sub>) at the lower airway pressure (P<sub>Low</sub>), set by non-invasive, breath-to-breath real-time spirometry, to terminate expiratory flow at a precise percentage of the peak expiratory flow rate, thereby preventing alveolar collapse regardless of respiratory system compliance (C<sub>RS</sub>). Adaptation to lung mechanics occurs through T<sub>Low</sub> adjustment, while adaptation to ventilation and PaCO&#x2082; occurs through time at the upper airway pressure (T<sub>High</sub>) adjustment. By modifying T<sub>High</sub> and T<sub>Low</sub> in response to changes in mechanics and ventilation needs, whether improving or declining, the ventilator provides individualized, physiology-guided support that preserves recruitment (T<sub>Low</sub>) while effectively balancing PaCO&#x2082; control (T<sub>High</sub>) and initiating airspace reopening (i.e., the longest T<sub>High</sub> that maintains adequate ventilation). The upper airway pressure (P<sub>High</sub>) is primarily analogous to a plateau pressure (Pplat) in conventional modes. Modifications to the P<sub>High</sub> are limited to circumstances in which tidal volume (V<sub>T</sub>) is &#x003C;4&#x202F;mL/kg and a significant chest wall component is present, resulting in a decline in overall C<sub>RS</sub>. The recommended protocol has the potential to prevent ARDS by reducing tissue stress and strain through lung stabilization. Its prolonged T<sub>High</sub> initiates recruitment while the brief, spirometry-guided T<sub>Low</sub> minimizes dynamic airspace opening and closing, reducing the mechanical injury that drives ARDS development. By limiting these injurious forces, optimally set APRV offers a protective strategy for patients at risk.</p>
<sec id="sec37">
<title>Limitations</title>
<p>This work has several important limitations. First, the recommendations are informed by expert consensus and therefore subject to the inherent biases of expert opinion, including variability in clinical experience, institutional practice patterns, and interpretation of the existing literature. Although efforts were made to include a multidisciplinary and geographically diverse panel, consensus statements cannot fully substitute for prospective empirical validation.</p>
<p>Second, there is a lack of large-scale randomized controlled trial data evaluating the impact of this specific protocol on patient-centered outcomes such as mortality, ventilator-free days, or long-term functional recovery. While the protocol is grounded in established physiologic principles and supported by mechanistic and observational data, definitive conclusions regarding its superiority over alternative strategies cannot be drawn in the absence of adequately powered randomized trials.</p>
<p>Finally, the application of a structured protocol to patients with ARDS is challenged by the marked heterogeneity of the syndrome, including differences in etiology, disease severity, lung recruitability, chest wall mechanics, and temporal evolution. Although the protocol is designed to be adaptive and physiology-guided, its implementation may require clinician judgment and individualized adjustment to account for patient-specific factors that are not fully captured by standardized settings.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec38">
<title>Conclusion</title>
<p>Based on available physiologic data and clinical experience, patients with early, recruitable lung injury&#x2014;particularly those with moderate to severe hypoxemia, high &#x0394;P, or evidence of tidal derecruitment on conventional ventilation&#x2014;are most likely to derive benefit. Early initiation, before the establishment of extensive alveolar collapse, edema, and fibroproliferation, may optimize the protocol&#x2019;s ability to stabilize alveoli, reduce cyclic opening and closing, and limit ventilator-induced lung injury.</p>
<p>However, given the heterogeneity of ARDS and the absence of large, definitive randomized trials addressing these questions, we intentionally avoid rigid inclusion criteria or timing thresholds. Instead, we emphasize a physiology-guided approach in which APRV is considered when conventional strategies fail to maintain adequate oxygenation or lung stability without injurious pressures, and when real-time assessment of respiratory mechanics suggests ongoing derecruitment. Future prospective studies stratified by ARDS phenotype, timing of initiation, and recruitability are needed to define patient selection and optimal timing more precisely.</p>
<p>The goal of this consensus guidelines conference was to recommend APRV settings that have demonstrated excellent clinical results across multiple hospitals when used by experts over many years. It outlines recommendations for setting and adjusting the four APRV parameters (P<sub>High</sub>, T<sub>High</sub>, P<sub>Low</sub>, T<sub>Low</sub>) and discusses the scientific evidence supporting these suggestions. Our recommendations closely align with the TCAV method for setting and adjusting the APRV mode and function as a closed-loop system, maintaining an open and stable lung in response to changing lung pathophysiology (<xref ref-type="fig" rid="fig11">Figure 11</xref>). The faculty hopes that these guidelines will serve as a starting point for clinicians interested in adopting APRV for their patients and guide more homogenous studies investigating APRV.</p>
<fig position="float" id="fig11">
<label>Figure 11</label>
<caption>
<p>The time-controlled adaptive ventilation (TCAV) method for setting airway pressure release ventilation (APRV) is a closed-loop system guided by changes in respiratory system compliance (C<sub>RS</sub>), which helps maintain lung stability as lung conditions change. The input to this closed-loop system is a stable, open lung. The controller uses <xref ref-type="disp-formula" rid="E1">Equation 1</xref> (F<sub>PE</sub> x 75%&#x202F;=&#x202F;F<sub>EE</sub>) to calculate the effector: expiratory duration (T<sub>Low</sub>). T<sub>Low</sub> must be sufficiently brief to prevent alveoli with rapid collapse time constants from collapsing. The physiological output is the change in C<sub>RS</sub>. The slope of the expiratory flow curve (Slope<sub>EF</sub>) acts as the sensor, measuring breath-by-breath changes in C<sub>RS</sub>. Slope<sub>EF</sub> functions like spirometry to identify lung pathophysiology. The sensor adjusts the controller to maintain the desired input (<xref ref-type="bibr" rid="ref5">5</xref>). When C<sub>RS</sub> decreases, Slope<sub>EF</sub> becomes steeper, leading T<sub>Low</sub> to be shortened to prevent alveoli with fast time constants from collapsing.</p>
</caption>
<graphic xlink:href="fmed-13-1741129-g011.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Diagram titled "TCAV Closed-Loop System Controlling Lung Stability" showing a process flow: Input labeled "Open and Stable Lung" to Controller ("FPE &#x00D7; 75% = FEE"), to Effector ("Expiratory Duration TLow"), to Output (arrows indicating change in CRS). A sensor labeled "SlopeEF" is connected from Output to Controller.</alt-text>
</graphic>
</fig>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec39">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="author-contributions" id="sec40">
<title>Author contributions</title>
<p>GN: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. JB: Project administration, Methodology, Validation, Formal analysis, Visualization, Supervision, Data curation, Software, Funding acquisition, Writing &#x2013; original draft, Resources, Investigation, Conceptualization, Writing &#x2013; review &#x0026; editing. PA: Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft. LR: Writing &#x2013; review &#x0026; editing, Methodology, Writing &#x2013; original draft. JSh: Writing &#x2013; review &#x0026; editing. JA: Writing &#x2013; review &#x0026; editing. LA: Writing &#x2013; review &#x0026; editing. MarM: Writing &#x2013; review &#x0026; editing. TM: Writing &#x2013; review &#x0026; editing. JSa: Writing &#x2013; review &#x0026; editing. TV: Writing &#x2013; review &#x0026; editing. HA-k: Writing &#x2013; review &#x0026; editing. ManM: Writing &#x2013; review &#x0026; editing. PS: Writing &#x2013; review &#x0026; editing. LF: Writing &#x2013; review &#x0026; editing. JD: Writing &#x2013; review &#x0026; editing. LC: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. NH: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="COI-statement" id="sec41">
<title>Conflict of interest</title>
<p>JB is a consultant for and shareholder in Oscillavent Inc. (Iowa) and Respiratory Sciences Inc. (Minnesota); received consulting fees from Chiesi USA, Inc and Royalties from Springer; and holds an R01 grant (HL142702) from NHLBI. GN is an unpaid lectures on the topic of APRV/TCAV, book published by Springer, including the science of APRV/TCAV efficacy. Co-investigator on an R01 grant (HL142702) from NHLBI, papers published on the clinical application of APRV. PA is an ICON employee, unpaid lectures on the topic of APRV/TCAV, papers published on the clinical application of APRV. JSh is an unpaid lectures on the topic of APRV/TCAV; edited books published by Springer, papers published on the clinical application of APRV. JA published a paper on the use of APRV/TCAV. MarM is an Unpaid lectures on the topic of APRV/TCAV, ICON employee, papers published on the clinical application of APRV. TM is an Unpaid lectures on the topic of APRV/TCAV. LC is a principal investigator of a randomized controlled trial using APRV on ARDS patients. Papers published on the clinical application of APRV. NH is patents in the field of mechanical ventilation, founder ICON, Book published by Springer, Unpaid lectures on the topic of APRV/TCAV. TV was Principal Investigator of a randomized controlled trial using APRV on ARDS patients.</p>
<p>The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="sec42">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec43">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec44">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2026.1741129/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmed.2026.1741129/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.png" id="SM1" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_2.jpeg" id="SM2" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_3.png" id="SM3" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_4.jpeg" id="SM4" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_5.png" id="SM5" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_6.png" id="SM6" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_7.png" id="SM7" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_8.png" id="SM8" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_9.png" id="SM9" mimetype="image/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_1.docx" id="SM10" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.docx" id="SM11" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.docx" id="SM12" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.xlsx" id="SM13" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_5.docx" id="SM14" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_6.docx" id="SM15" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_7.xlsx" id="SM16" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_8.xlsx" id="SM17" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_9.docx" id="SM18" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_10.docx" id="SM19" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_11.docx" id="SM20" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_12.xlsx" id="SM21" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_13.docx" id="SM22" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downs</surname><given-names>JB</given-names></name> <name><surname>Stock</surname><given-names>MC</given-names></name></person-group>. <article-title>Airway pressure release ventilation: a new concept in ventilatory support</article-title>. <source>Crit Care Med</source>. (<year>1987</year>) <volume>15</volume>:<fpage>459</fpage>&#x2013;<lpage>61</lpage>.</mixed-citation></ref>
<ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SV</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Sadowitz</surname><given-names>B</given-names></name> <name><surname>Dombert</surname><given-names>L</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <etal/></person-group>. <article-title>The 30-year evolution of airway pressure release ventilation (APRV)</article-title>. <source>Intensive Care Med Exp</source>. (<year>2016</year>) <volume>4</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40635-016-0085-2</pub-id>, <pub-id pub-id-type="pmid">27207149</pub-id></mixed-citation></ref>
<ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzenschlager</surname><given-names>S</given-names></name> <name><surname>Simon</surname><given-names>CM</given-names></name> <name><surname>Rehn</surname><given-names>P</given-names></name> <name><surname>Grilli</surname><given-names>M</given-names></name> <name><surname>Fiedler</surname><given-names>MO</given-names></name> <name><surname>M&#x00FC;ller</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Time-controlled adaptive ventilation in patients with ARDS-lack of protocol adherence: a systematic review</article-title>. <source>Crit Care</source>. (<year>2023</year>) <volume>27</volume>:<fpage>57</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-023-04340-w</pub-id>, <pub-id pub-id-type="pmid">36765424</pub-id></mixed-citation></ref>
<ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>MR</given-names></name> <name><surname>Charlamb</surname><given-names>J</given-names></name> <name><surname>Kenna</surname><given-names>JR</given-names></name> <name><surname>Smith</surname><given-names>A</given-names></name> <name><surname>Glatt</surname><given-names>SJ</given-names></name> <name><surname>Araos</surname><given-names>JD</given-names></name> <etal/></person-group>. <article-title>Inconsistent methods used to set airway pressure release ventilation in acute respiratory distress syndrome: a systematic review and meta-regression analysis</article-title>. <source>J Clin Med</source>. (<year>2024</year>) <volume>13</volume>:<fpage>2690</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm13092690</pub-id>, <pub-id pub-id-type="pmid">38731219</pub-id></mixed-citation></ref>
<ref id="ref5"><label>5.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Habashi</surname><given-names>NM</given-names></name></person-group>. <source>Applied physiology to reduce ventilator induced lung injury: Clinical applications for the acutely injured lung</source>. <edition>1st</edition> ed. <publisher-loc>Cham</publisher-loc>: <publisher-name>Springer Nature Switzerland</publisher-name> (<year>2024</year>).</mixed-citation></ref>
<ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>MB</given-names></name> <name><surname>Meade</surname><given-names>MO</given-names></name> <name><surname>Slutsky</surname><given-names>AS</given-names></name> <name><surname>Brochard</surname><given-names>L</given-names></name> <name><surname>Costa</surname><given-names>EL</given-names></name> <name><surname>Schoenfeld</surname><given-names>DA</given-names></name> <etal/></person-group>. <article-title>Driving pressure and survival in the acute respiratory distress syndrome</article-title>. <source>N Engl J Med</source>. (<year>2015</year>) <volume>372</volume>:<fpage>747</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMsa1410639</pub-id>, <pub-id pub-id-type="pmid">25693014</pub-id></mixed-citation></ref>
<ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L</given-names></name> <name><surname>Wang</surname><given-names>W</given-names></name> <name><surname>Zhao</surname><given-names>N</given-names></name> <name><surname>Guo</surname><given-names>L</given-names></name> <name><surname>Chi</surname><given-names>C</given-names></name> <name><surname>Hou</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis</article-title>. <source>Crit Care</source>. (<year>2016</year>) <volume>20</volume>:<fpage>226</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-016-1396-0</pub-id>, <pub-id pub-id-type="pmid">27448995</pub-id></mixed-citation></ref>
<ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname><given-names>GH</given-names></name> <name><surname>Oxman</surname><given-names>AD</given-names></name> <name><surname>Kunz</surname><given-names>R</given-names></name> <name><surname>Atkins</surname><given-names>D</given-names></name> <name><surname>Brozek</surname><given-names>J</given-names></name> <name><surname>Vist</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>GRADE guidelines: 2. Framing the question and deciding on important outcomes</article-title>. <source>J Clin Epidemiol</source>. (<year>2011</year>) <volume>64</volume>:<fpage>395</fpage>&#x2013;<lpage>400</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.09.012</pub-id>, <pub-id pub-id-type="pmid">21194891</pub-id></mixed-citation></ref>
<ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab id="coll1">ARDS Definition Task Force</collab><name><surname>Ranieri</surname><given-names>VM</given-names></name> <name><surname>Rubenfeld</surname><given-names>GD</given-names></name> <name><surname>Thompson</surname><given-names>BT</given-names></name> <name><surname>Ferguson</surname><given-names>ND</given-names></name> <name><surname>Caldwell</surname><given-names>E</given-names></name> <etal/></person-group>. <article-title>Acute respiratory distress syndrome: the Berlin definition</article-title>. <source>JAMA</source>. (<year>2012</year>) <volume>307</volume>:<fpage>2526</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2012.5669</pub-id></mixed-citation></ref>
<ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carney</surname><given-names>DE</given-names></name> <name><surname>Bredenberg</surname><given-names>CE</given-names></name> <name><surname>Schiller</surname><given-names>HJ</given-names></name> <name><surname>Picone</surname><given-names>AL</given-names></name> <name><surname>McCann</surname><given-names>UG</given-names></name> <name><surname>Gatto</surname><given-names>LA</given-names></name> <etal/></person-group>. <article-title>The mechanism of lung volume change during mechanical ventilation</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>1999</year>) <volume>160</volume>:<fpage>1697</fpage>&#x2013;<lpage>702</lpage>.</mixed-citation></ref>
<ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Jain</surname><given-names>S</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Smith</surname><given-names>BJ</given-names></name> <name><surname>Hamlington-Smith</surname><given-names>KL</given-names></name> <name><surname>Roy</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Effect of airway pressure release ventilation on dynamic alveolar heterogeneity</article-title>. <source>JAMA Surg</source>. (<year>2016</year>) <volume>151</volume>:<fpage>64</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamasurg.2015.2683</pub-id>, <pub-id pub-id-type="pmid">26444302</pub-id></mixed-citation></ref>
<ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Emr</surname><given-names>B</given-names></name> <name><surname>Smith</surname><given-names>B</given-names></name> <name><surname>Roy</surname><given-names>S</given-names></name> <name><surname>Jain</surname><given-names>S</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Mechanical breath profile of airway pressure release ventilation: the effect on alveolar recruitment and microstrain in acute lung injury</article-title>. <source>JAMA Surg</source>. (<year>2014</year>) <volume>149</volume>:<fpage>1138</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamasurg.2014.1829</pub-id>, <pub-id pub-id-type="pmid">25230047</pub-id></mixed-citation></ref>
<ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Emr</surname><given-names>B</given-names></name> <name><surname>Smith</surname><given-names>B</given-names></name> <name><surname>Ruiz</surname><given-names>C</given-names></name> <name><surname>Roy</surname><given-names>S</given-names></name> <name><surname>Meng</surname><given-names>Q</given-names></name> <etal/></person-group>. <article-title>Airway pressure release ventilation reduces conducting airway micro-strain in lung injury</article-title>. <source>J Am Coll Surg</source>. (<year>2014</year>) <volume>219</volume>:<fpage>968</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2014.09.011</pub-id>, <pub-id pub-id-type="pmid">25440027</pub-id></mixed-citation></ref>
<ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramcharran</surname><given-names>H</given-names></name> <name><surname>Wetmore</surname><given-names>G</given-names></name> <name><surname>Cooper</surname><given-names>S</given-names></name> <name><surname>Herrmann</surname><given-names>J</given-names></name> <name><surname>da Fonseca Cruz</surname><given-names>A</given-names></name> <name><surname>Kaczka</surname><given-names>DW</given-names></name> <etal/></person-group>. <article-title>Effects of lung injury and abdominal insufflation on respiratory mechanics and lung volume during time-controlled adaptive ventilation</article-title>. <source>Respir Care</source>. (<year>2024</year>) <volume>69</volume>:<fpage>1432</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.4187/respcare.11745</pub-id>, <pub-id pub-id-type="pmid">38408775</pub-id></mixed-citation></ref>
<ref id="ref15"><label>15.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll2">Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators</collab><name><surname>Cavalcanti</surname><given-names>AB</given-names></name> <name><surname>Suzumura</surname><given-names>&#x00C9;A</given-names></name> <name><surname>Laranjeira</surname><given-names>LN</given-names></name> <name><surname>de Moraes Paisani</surname><given-names>D</given-names></name> <name><surname>Damiani</surname><given-names>LP</given-names></name> <etal/></person-group>. <article-title>Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial</article-title>. <source>JAMA</source>. (<year>2017</year>) <volume>318</volume>:<fpage>1335</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2017.14171</pub-id>,</mixed-citation></ref>
<ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maca</surname><given-names>J</given-names></name> <name><surname>Jor</surname><given-names>O</given-names></name> <name><surname>Holub</surname><given-names>M</given-names></name> <name><surname>Sklienka</surname><given-names>P</given-names></name> <name><surname>Bur&#x0161;a</surname><given-names>F</given-names></name> <name><surname>Burda</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Past and present ARDS mortality rates: a systematic review</article-title>. <source>Respir Care</source>. (<year>2017</year>) <volume>62</volume>:<fpage>113</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.4187/respcare.04716</pub-id>, <pub-id pub-id-type="pmid">27803355</pub-id></mixed-citation></ref>
<ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellani</surname><given-names>G</given-names></name> <name><surname>Laffey</surname><given-names>JG</given-names></name> <name><surname>Pham</surname><given-names>T</given-names></name> <name><surname>Fan</surname><given-names>E</given-names></name> <name><surname>Brochard</surname><given-names>L</given-names></name> <name><surname>Esteban</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries</article-title>. <source>JAMA</source>. (<year>2016</year>) <volume>315</volume>:<fpage>788</fpage>&#x2013;<lpage>800</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2016.0291</pub-id>, <pub-id pub-id-type="pmid">26903337</pub-id></mixed-citation></ref>
<ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wick</surname><given-names>KD</given-names></name> <name><surname>Ware</surname><given-names>LB</given-names></name> <name><surname>Matthay</surname><given-names>MA</given-names></name></person-group>. <article-title>Acute respiratory distress syndrome</article-title>. <source>BMJ</source>. (<year>2024</year>) <volume>387</volume>:<fpage>e076612</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj-2023-076612</pub-id>, <pub-id pub-id-type="pmid">39467606</pub-id></mixed-citation></ref>
<ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Shiber</surname><given-names>J</given-names></name> <name><surname>Madden</surname><given-names>M</given-names></name> <name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Camporota</surname><given-names>L</given-names></name> <name><surname>Habashi</surname><given-names>NM</given-names></name></person-group>. <article-title>Myths and misconceptions of airway pressure release ventilation: getting past the noise and on to the signal</article-title>. <source>Front Physiol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>928562</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2022.928562</pub-id>, <pub-id pub-id-type="pmid">35957991</pub-id></mixed-citation></ref>
<ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Magalhaes</surname><given-names>RF</given-names></name> <name><surname>Cruz</surname><given-names>DG</given-names></name> <name><surname>Antunes</surname><given-names>MA</given-names></name> <name><surname>Fernandes</surname><given-names>MV d S</given-names></name> <name><surname>Oliveira</surname><given-names>MV</given-names></name> <name><surname>Braga</surname><given-names>CL</given-names></name> <etal/></person-group>. <article-title>Time-controlled adaptive ventilation versus volume-controlled ventilation in experimental pneumonia</article-title>. <source>Crit Care Med</source>. (<year>2021</year>) <volume>49</volume>:<fpage>33060501</fpage>:<fpage>140</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1097/CCM.0000000000004675</pub-id></mixed-citation></ref>
<ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>RA</given-names></name> <name><surname>Green</surname><given-names>JM</given-names></name> <name><surname>Waldrop</surname><given-names>J</given-names></name> <name><surname>Dart</surname><given-names>BW</given-names></name> <name><surname>Smith</surname><given-names>PW</given-names></name> <name><surname>Brooks</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>A randomized prospective trial of airway pressure release ventilation and low tidal volume ventilation in adult trauma patients with acute respiratory failure</article-title>. <source>J Trauma</source>. (<year>2010</year>) <volume>69</volume>:<fpage>501</fpage>&#x2013;<lpage>10</lpage>; <comment>discussion 511</comment>. doi: <pub-id pub-id-type="doi">10.1097/TA.0b013e3181e75961</pub-id></mixed-citation></ref>
<ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydow</surname><given-names>M</given-names></name> <name><surname>Burchardi</surname><given-names>H</given-names></name> <name><surname>Ephraim</surname><given-names>E</given-names></name> <name><surname>Zielmann</surname><given-names>S</given-names></name> <name><surname>Crozier</surname><given-names>TA</given-names></name></person-group>. <article-title>Long-term effects of two different ventilatory modes on oxygenation in acute lung injury. Comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>1994</year>) <volume>149</volume>:<fpage>1550</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1164/ajrccm.149.6.8004312</pub-id>, <pub-id pub-id-type="pmid">8004312</pub-id></mixed-citation></ref>
<ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>X</given-names></name> <name><surname>Wu</surname><given-names>Q</given-names></name> <name><surname>Yang</surname><given-names>H</given-names></name> <name><surname>Dong</surname><given-names>W</given-names></name> <name><surname>Wang</surname><given-names>B</given-names></name> <name><surname>Zhang</surname><given-names>Z</given-names></name> <etal/></person-group>. <article-title>Airway pressure release ventilation versus low tidal volume ventilation for patients with acute respiratory distress syndrome/acute lung injury: a meta-analysis of randomized clinical trials</article-title>. <source>Ann Transl Med</source>. (<year>2020</year>) <volume>8</volume>:<fpage>1641</fpage>. doi: <pub-id pub-id-type="doi">10.21037/atm-20-6917</pub-id>, <pub-id pub-id-type="pmid">33490153</pub-id></mixed-citation></ref>
<ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carsetti</surname><given-names>A</given-names></name> <name><surname>Damiani</surname><given-names>E</given-names></name> <name><surname>Domizi</surname><given-names>R</given-names></name> <name><surname>Scorcella</surname><given-names>C</given-names></name> <name><surname>Pantanetti</surname><given-names>S</given-names></name> <name><surname>Falcetta</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Airway pressure release ventilation during acute hypoxemic respiratory failure: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Ann Intensive Care</source>. (<year>2019</year>) <volume>9</volume>:<fpage>44</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13613-019-0518-7</pub-id>, <pub-id pub-id-type="pmid">30949778</pub-id></mixed-citation></ref>
<ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibert</surname><given-names>K</given-names></name> <name><surname>Garcia-Alonso</surname><given-names>C</given-names></name> <name><surname>Salvador-Carulla</surname><given-names>L</given-names></name></person-group>. <article-title>Integrating clinicians, knowledge and data: expert-based cooperative analysis in healthcare decision support</article-title>. <source>Health Res Policy Syst</source>. (<year>2010</year>) <volume>8</volume>:<fpage>28</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1478-4505-8-28</pub-id>, <pub-id pub-id-type="pmid">20920289</pub-id></mixed-citation></ref>
<ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>A</given-names></name> <name><surname>Sturmberg</surname><given-names>J</given-names></name> <name><surname>Lukersmith</surname><given-names>S</given-names></name> <name><surname>Madden</surname><given-names>R</given-names></name> <name><surname>Torkfar</surname><given-names>G</given-names></name> <name><surname>Colagiuri</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>Evidence-based medicine: is it a bridge too far?</article-title> <source>Health Res Policy Syst</source>. (<year>2015</year>) <volume>13</volume>:<fpage>66</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12961-015-0057-0</pub-id>, <pub-id pub-id-type="pmid">26546273</pub-id></mixed-citation></ref>
<ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brozek</surname><given-names>JL</given-names></name> <name><surname>Akl</surname><given-names>EA</given-names></name> <name><surname>Alonso-Coello</surname><given-names>P</given-names></name> <name><surname>Lang</surname><given-names>D</given-names></name> <name><surname>Jaeschke</surname><given-names>R</given-names></name> <name><surname>Williams</surname><given-names>JW</given-names></name> <etal/></person-group>. <article-title>Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions</article-title>. <source>Allergy</source>. (<year>2009</year>) <volume>64</volume>:<fpage>669</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1398-9995.2009.01973.x</pub-id></mixed-citation></ref>
<ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name> <name><surname>Habashi</surname><given-names>N</given-names></name> <name><surname>Sadowitz</surname><given-names>B</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Ge</surname><given-names>L</given-names></name> <name><surname>Wang</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>Early airway pressure release ventilation prevents ARDS-a novel preventive approach to lung injury</article-title>. <source>Shock</source>. (<year>2013</year>) <volume>39</volume>:<fpage>28</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0b013e31827b47bb</pub-id>, <pub-id pub-id-type="pmid">23247119</pub-id></mixed-citation></ref>
<ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>JHT</given-names></name> <name><surname>Kaczka</surname><given-names>DW</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Gaver</surname><given-names>DP</given-names></name></person-group>. <article-title>Atelectrauma can be avoided if expiration is sufficiently brief: evidence from inverse modeling and oscillometry during airway pressure release ventilation</article-title>. <source>Crit Care</source>. (<year>2024</year>) <volume>28</volume>:<fpage>329</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-024-05112-w</pub-id>, <pub-id pub-id-type="pmid">39380082</pub-id></mixed-citation></ref>
<ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>JHT</given-names></name> <name><surname>Kaczka</surname><given-names>DW</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Gaver</surname><given-names>DP</given-names><suffix>3rd</suffix></name></person-group>. <article-title>Mechanical power and ventilator-induced lung injury: what does physics have to say?</article-title> <source>Am J Respir Crit Care Med</source>. (<year>2024</year>) <volume>209</volume>:<fpage>787</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.202307-1292VP</pub-id>, <pub-id pub-id-type="pmid">37729623</pub-id></mixed-citation></ref>
<ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>JHT</given-names></name> <name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Gaver</surname><given-names>DP</given-names></name></person-group>. <article-title>Ventilator-induced lung injury as a dynamic balance between epithelial cell damage and recovery</article-title>. <source>Ann Biomed Eng</source>. (<year>2023</year>) <volume>51</volume>:<fpage>1052</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10439-023-03186-1</pub-id>, <pub-id pub-id-type="pmid">37000319</pub-id></mixed-citation></ref>
<ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name> <name><surname>Fujioka</surname><given-names>H</given-names></name> <name><surname>Halpern</surname><given-names>D</given-names></name> <name><surname>Bates</surname><given-names>JHT</given-names></name> <name><surname>Gaver</surname><given-names>DP</given-names></name></person-group>. <article-title>Full-lung simulations of mechanically ventilated lungs incorporating recruitment/derecruitment dynamics</article-title>. <source>Front Netw Physiol</source>. (<year>2023</year>) <volume>3</volume>:<fpage>1257710</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnetp.2023.1257710</pub-id>, <pub-id pub-id-type="pmid">38020240</pub-id></mixed-citation></ref>
<ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>AF</given-names></name> <name><surname>Herrmann</surname><given-names>J</given-names></name> <name><surname>Ramcharran</surname><given-names>H</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Tawhai</surname><given-names>MH</given-names></name> <name><surname>Bates</surname><given-names>JHT</given-names></name> <etal/></person-group>. <article-title>Sustained vs. Intratidal recruitment in the injured lung during airway pressure release ventilation: a computational modeling perspective</article-title>. <source>Mil Med</source>. (<year>2023</year>) <volume>188</volume>:<fpage>141</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1093/milmed/usad059</pub-id>, <pub-id pub-id-type="pmid">37948236</pub-id></mixed-citation></ref>
<ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joy</surname><given-names>W</given-names></name> <name><surname>Albanese</surname><given-names>B</given-names></name> <name><surname>Oakley</surname><given-names>D</given-names></name> <name><surname>Mistry</surname><given-names>S</given-names></name> <name><surname>Nikulina</surname><given-names>K</given-names></name> <name><surname>Schuppert</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Digital twins to evaluate the risk of ventilator-induced lung injury during airway pressure release ventilation compared with pressure-controlled ventilation</article-title>. <source>Crit Care Med</source>. (<year>2025</year>) <volume>53</volume>:<fpage>e2573</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ccm.0000000000006885</pub-id>, <pub-id pub-id-type="pmid">40990606</pub-id></mixed-citation></ref>
<ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>SP</given-names></name> <name><surname>DiRocco</surname><given-names>J</given-names></name> <name><surname>Allen</surname><given-names>GB</given-names></name> <name><surname>Bates</surname><given-names>JH</given-names></name> <name><surname>Lafollette</surname><given-names>R</given-names></name> <name><surname>Kubiak</surname><given-names>BD</given-names></name> <etal/></person-group>. <article-title>The role of time and pressure on alveolar recruitment</article-title>. <source>J Appl Physiol (1985)</source>. (<year>2009</year>) <volume>106</volume>:<fpage>757</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1152/japplphysiol.90735.2008</pub-id>, <pub-id pub-id-type="pmid">19074576</pub-id></mixed-citation></ref>
<ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>BJ</given-names></name> <name><surname>Lundblad</surname><given-names>LKA</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Nieman</surname><given-names>G</given-names></name> <name><surname>Habashi</surname><given-names>N</given-names></name> <etal/></person-group>. <article-title>Predicting the response of the injured lung to the mechanical breath profile</article-title>. <source>J Appl Physiol</source>. (<year>2015</year>) <volume>118</volume>:<fpage>932</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1152/japplphysiol.00902.2014</pub-id>, <pub-id pub-id-type="pmid">25635004</pub-id></mixed-citation></ref>
<ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marini</surname><given-names>JJ</given-names></name> <name><surname>Gattinoni</surname><given-names>L</given-names></name></person-group>. <article-title>Time course of evolving ventilator-induced lung injury: the "shrinking baby lung"</article-title>. <source>Crit Care Med</source>. (<year>2020</year>) <volume>48</volume>:<fpage>1203</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1097/CCM.0000000000004416</pub-id>, <pub-id pub-id-type="pmid">32697492</pub-id></mixed-citation></ref>
<ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>G</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Ramcharran</surname><given-names>H</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Blair</surname><given-names>S</given-names></name> <name><surname>Gatto</surname><given-names>LA</given-names></name> <etal/></person-group>. <article-title>Unshrinking the baby lung to calm the VILI vortex</article-title>. <source>Crit Care</source>. (<year>2022</year>) <volume>26</volume>:<fpage>242</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-022-04105-x</pub-id>, <pub-id pub-id-type="pmid">35934707</pub-id></mixed-citation></ref>
<ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Wilcox</surname><given-names>K</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Madden</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Acute lung injury: how to stabilize a broken lung</article-title>. <source>Crit Care</source>. (<year>2018</year>) <volume>22</volume>:<fpage>136</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-018-2051-8</pub-id>, <pub-id pub-id-type="pmid">29793554</pub-id></mixed-citation></ref>
<ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SV</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Searles</surname><given-names>Q</given-names></name> <name><surname>Dombert</surname><given-names>L</given-names></name> <name><surname>Abdel-Razek</surname><given-names>O</given-names></name> <etal/></person-group>. <article-title>The role of high airway pressure and dynamic strain on ventilator-induced lung injury in a heterogeneous acute lung injury model</article-title>. <source>Intensive Care Med Exp</source>. (<year>2017</year>) <volume>5</volume>:<fpage>25</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40635-017-0138-1</pub-id>, <pub-id pub-id-type="pmid">28497420</pub-id></mixed-citation></ref>
<ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramcharran</surname><given-names>H</given-names></name> <name><surname>Bates</surname><given-names>JHT</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Blair</surname><given-names>S</given-names></name> <name><surname>Andrews</surname><given-names>PL</given-names></name> <name><surname>Gaver</surname><given-names>DP</given-names></name> <etal/></person-group>. <article-title>Protective ventilation in a pig model of acute lung injury: timing is as important as pressure</article-title>. <source>J Appl Physiol</source>. (<year>2022</year>) <volume>133</volume>:<fpage>1093</fpage>&#x2013;<lpage>105</lpage>. doi: <pub-id pub-id-type="doi">10.1152/japplphysiol.00312.2022</pub-id>, <pub-id pub-id-type="pmid">36135956</pub-id></mixed-citation></ref>
<ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>T</given-names></name> <name><surname>Hueter</surname><given-names>L</given-names></name> <name><surname>Gaser</surname><given-names>E</given-names></name> <name><surname>Schmidt</surname><given-names>B</given-names></name> <name><surname>Schwarzkopf</surname><given-names>K</given-names></name> <name><surname>Rek</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>PEEP has beneficial effects on inflammation in the injured and no deleterious effects on the noninjured lung after unilateral lung acid instillation</article-title>. <source>Intensive Care Med</source>. (<year>2006</year>) <volume>32</volume>:<fpage>740</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00134-006-0117-6</pub-id>, <pub-id pub-id-type="pmid">16534568</pub-id></mixed-citation></ref>
<ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protti</surname><given-names>A</given-names></name> <name><surname>Andreis</surname><given-names>DT</given-names></name> <name><surname>Monti</surname><given-names>M</given-names></name> <name><surname>Santini</surname><given-names>A</given-names></name> <name><surname>Sparacino</surname><given-names>CC</given-names></name> <name><surname>Langer</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>Lung stress and strain during mechanical ventilation: any difference between statics and dynamics?</article-title> <source>Crit Care Med</source>. (<year>2013</year>) <volume>41</volume>:<fpage>1046</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1097/CCM.0b013e31827417a6</pub-id></mixed-citation></ref>
<ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seah</surname><given-names>AS</given-names></name> <name><surname>Grant</surname><given-names>KA</given-names></name> <name><surname>Aliyeva</surname><given-names>M</given-names></name> <name><surname>Allen</surname><given-names>GB</given-names></name> <name><surname>Bates</surname><given-names>JHT</given-names></name></person-group>. <article-title>Quantifying the roles of tidal volume and PEEP in the pathogenesis of ventilator-induced lung injury</article-title>. <source>Ann Biomed Eng</source>. (<year>2011</year>) <volume>39</volume>:<fpage>1505</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10439-010-0237-6</pub-id>, <pub-id pub-id-type="pmid">21203845</pub-id></mixed-citation></ref>
<ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name> <name><surname>Pesenti</surname><given-names>A</given-names></name></person-group>. <article-title>The concept of "baby lung"</article-title>. <source>Intensive Care Med</source>. (<year>2005</year>) <volume>31</volume>:<fpage>776</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00134-005-2627-z</pub-id>, <pub-id pub-id-type="pmid">15812622</pub-id></mixed-citation></ref>
<ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulain</surname><given-names>T</given-names></name> <name><surname>Achard</surname><given-names>J-M</given-names></name> <name><surname>Teboul</surname><given-names>J-L</given-names></name> <name><surname>Richard</surname><given-names>C</given-names></name> <name><surname>Perrotin</surname><given-names>D</given-names></name> <name><surname>Ginies</surname><given-names>G</given-names></name></person-group>. <article-title>Changes in BP induced by passive leg raising predict response to fluid loading in critically ill patients</article-title>. <source>Chest</source>. (<year>2002</year>) <volume>121</volume>:<fpage>1245</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.121.4.1245</pub-id>, <pub-id pub-id-type="pmid">11948060</pub-id></mixed-citation></ref>
<ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marik</surname><given-names>PE</given-names></name> <name><surname>Lemson</surname><given-names>J</given-names></name></person-group>. <article-title>Fluid responsiveness: an evolution of our understanding</article-title>. <source>Br J Anaesth</source>. (<year>2014</year>) <volume>112</volume>:<fpage>617</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bja/aet590</pub-id>, <pub-id pub-id-type="pmid">24535603</pub-id></mixed-citation></ref>
<ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nova</surname><given-names>A</given-names></name> <name><surname>Xin</surname><given-names>Y</given-names></name> <name><surname>Victor</surname><given-names>M</given-names></name> <name><surname>Gaulton</surname><given-names>TG</given-names></name> <name><surname>Alcala</surname><given-names>GC</given-names></name> <name><surname>Winkler</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>Biomechanical implications of mass loading in a swine model of acute hypoxemic respiratory failure</article-title>. <source>J Appl Physiol (1985)</source>. (<year>2025</year>) <volume>139</volume>:<fpage>849</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1152/japplphysiol.00377.2025</pub-id>, <pub-id pub-id-type="pmid">40864615</pub-id></mixed-citation></ref>
<ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Herrmann</surname><given-names>J</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Andrews</surname><given-names>PL</given-names></name> <name><surname>Habashi</surname><given-names>NM</given-names></name> <etal/></person-group>. <article-title>Ratchet recruitment in the acute respiratory distress syndrome: lessons from the newborn cry</article-title>. <source>Front Physiol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1287416</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2023.1287416</pub-id>, <pub-id pub-id-type="pmid">38028774</pub-id></mixed-citation></ref>
<ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Emr</surname><given-names>B</given-names></name> <name><surname>Jain</surname><given-names>SV</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Liu</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>The effects of airway pressure release ventilation on respiratory mechanics in extrapulmonary lung injury</article-title>. <source>Intensive Care Med Exp</source>. (<year>2015</year>) <volume>3</volume>:<fpage>35</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40635-015-0071-0</pub-id>, <pub-id pub-id-type="pmid">26694915</pub-id></mixed-citation></ref>
<ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>M</given-names></name> <name><surname>DiStefano</surname><given-names>D</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>al-Khalisy</surname><given-names>H</given-names></name> <name><surname>Baker</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Time-controlled adaptive ventilation (TCAV) accelerates simulated mucus clearance via increased expiratory flow rate</article-title>. <source>Intensive Care Med Exp</source>. (<year>2019</year>) <volume>7</volume>:<fpage>27</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40635-019-0250-5</pub-id>, <pub-id pub-id-type="pmid">31098761</pub-id></mixed-citation></ref>
<ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briel</surname><given-names>M</given-names></name> <name><surname>Meade</surname><given-names>M</given-names></name> <name><surname>Mercat</surname><given-names>A</given-names></name> <name><surname>Brower</surname><given-names>RG</given-names></name> <name><surname>Talmor</surname><given-names>D</given-names></name> <name><surname>Walter</surname><given-names>SD</given-names></name> <etal/></person-group>. <article-title>Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis</article-title>. <source>JAMA</source>. (<year>2010</year>) <volume>303</volume>:<fpage>865</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2010.218</pub-id></mixed-citation></ref>
<ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Gatto</surname><given-names>LA</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Camporota</surname><given-names>L</given-names></name> <name><surname>Daxon</surname><given-names>B</given-names></name> <etal/></person-group>. <article-title>Prevention and treatment of acute lung injury with time-controlled adaptive ventilation: physiologically informed modification of airway pressure release ventilation</article-title>. <source>Ann Intensive Care</source>. (<year>2020</year>) <volume>10</volume>:<fpage>3</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13613-019-0619-3</pub-id>, <pub-id pub-id-type="pmid">31907704</pub-id></mixed-citation></ref>
<ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Al-Khalisy</surname><given-names>H</given-names></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Blair</surname><given-names>S</given-names></name> <name><surname>Trikha</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>A physiologically informed strategy to effectively open, stabilize, and protect the acutely injured lung</article-title>. <source>Front Physiol</source>. (<year>2020</year>) <volume>11</volume>:<fpage>227</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2020.00227</pub-id>, <pub-id pub-id-type="pmid">32265734</pub-id></mixed-citation></ref>
<ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilek</surname><given-names>AM</given-names></name> <name><surname>Dee</surname><given-names>KC</given-names></name> <name><surname>Gaver</surname><given-names>DP</given-names><suffix>3rd</suffix></name></person-group>. <article-title>Mechanisms of surface-tension-induced epithelial cell damage in a model of pulmonary airway reopening</article-title>. <source>J Appl Physiol</source>. (<year>2003</year>) <volume>94</volume>:<fpage>770</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1152/japplphysiol.00764.2002</pub-id>, <pub-id pub-id-type="pmid">12433851</pub-id></mixed-citation></ref>
<ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaver</surname><given-names>DP</given-names><suffix>3rd</suffix></name> <name><surname>Kollisch-Singule</surname><given-names>M</given-names></name> <name><surname>Nieman</surname><given-names>G</given-names></name> <name><surname>Satalin</surname><given-names>J</given-names></name> <name><surname>Habashi</surname><given-names>N</given-names></name> <name><surname>Bates</surname><given-names>JHT</given-names></name></person-group>. <article-title>Mechanical ventilation energy analysis: recruitment focuses injurious power in the ventilated lung</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2025</year>) <volume>122</volume>:<fpage>e2419374122</fpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.2419374122</pub-id>, <pub-id pub-id-type="pmid">40030025</pub-id></mixed-citation></ref>
<ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>PL</given-names></name> <name><surname>Shiber</surname><given-names>JR</given-names></name> <name><surname>Jaruga-Killeen</surname><given-names>E</given-names></name> <name><surname>Roy</surname><given-names>S</given-names></name> <name><surname>Sadowitz</surname><given-names>B</given-names></name> <name><surname>O'Toole</surname><given-names>RV</given-names></name> <etal/></person-group>. <article-title>Early application of airway pressure release ventilation may reduce mortality in high-risk trauma patients: a systematic review of observational trauma ARDS literature</article-title>. <source>J Trauma Acute Care Surg</source>. (<year>2013</year>) <volume>75</volume>:<fpage>635</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1097/TA.0b013e31829d3504</pub-id>, <pub-id pub-id-type="pmid">24064877</pub-id></mixed-citation></ref>
<ref id="ref58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name> <name><surname>Sadowitz</surname><given-names>B</given-names></name> <name><surname>Andrews</surname><given-names>P</given-names></name> <name><surname>Gatto</surname><given-names>LA</given-names></name> <name><surname>Marx</surname><given-names>W</given-names></name> <name><surname>Ge</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Early stabilizing alveolar ventilation prevents acute respiratory distress syndrome: a novel timing-based ventilatory intervention to avert lung injury</article-title>. <source>J Trauma Acute Care Surg</source>. (<year>2012</year>) <volume>73</volume>:<fpage>391</fpage>&#x2013;<lpage>400</lpage>. doi: <pub-id pub-id-type="doi">10.1097/TA.0b013e31825c7a82</pub-id></mixed-citation></ref>
<ref id="ref59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>M</given-names></name> <name><surname>Meeder</surname><given-names>JHJ</given-names></name> <name><surname>Seghers</surname><given-names>L</given-names></name> <name><surname>den Uil</surname><given-names>C</given-names></name></person-group>. <article-title>Time controlled adaptive ventilation as conservative treatment of destroyed lung: an alternative to lung transplantation</article-title>. <source>BMC Pulm Med</source>. (<year>2021</year>) <volume>21</volume>:<fpage>176</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12890-021-01545-z</pub-id>, <pub-id pub-id-type="pmid">34022829</pub-id></mixed-citation></ref>
<ref id="ref60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rola</surname><given-names>P</given-names></name> <name><surname>Daxon</surname><given-names>B</given-names></name></person-group>. <article-title>Airway pressure release ventilation with time-controlled adaptive ventilation (TCAV) in COVID-19: a community hospital's experience</article-title>. <source>Front Physiol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>787231</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2022.787231</pub-id>, <pub-id pub-id-type="pmid">35480043</pub-id></mixed-citation></ref>
<ref id="ref61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stock</surname><given-names>MC</given-names></name> <name><surname>Downs</surname><given-names>JB</given-names></name> <name><surname>Frolicher</surname><given-names>DA</given-names></name></person-group>. <article-title>Airway pressure release ventilation</article-title>. <source>Crit Care Med</source>. (<year>1987</year>) <volume>15</volume>:<fpage>462</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00003246-198705000-00002</pub-id>, <pub-id pub-id-type="pmid">3552443</pub-id></mixed-citation></ref>
<ref id="ref62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>K</given-names><suffix>Jr</suffix></name> <name><surname>Johnson</surname><given-names>DJ</given-names></name> <name><surname>Branson</surname><given-names>RD</given-names></name> <name><surname>Campbell</surname><given-names>RS</given-names></name> <name><surname>Johannigman</surname><given-names>JA</given-names></name> <name><surname>Porembka</surname><given-names>D</given-names></name></person-group>. <article-title>Airway pressure release ventilation</article-title>. <source>Arch Surg</source>. (<year>1993</year>) <volume>128</volume>:<fpage>1348</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archsurg.1993.01420240056010</pub-id>, <pub-id pub-id-type="pmid">8250707</pub-id></mixed-citation></ref>
<ref id="ref63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gama de Abreu</surname><given-names>M</given-names></name> <name><surname>Cuevas</surname><given-names>M</given-names></name> <name><surname>Spieth</surname><given-names>PM</given-names></name> <name><surname>Carvalho</surname><given-names>AR</given-names></name> <name><surname>Hietschold</surname><given-names>V</given-names></name> <name><surname>Stroszczynski</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>Regional lung aeration and ventilation during pressure support and biphasic positive airway pressure ventilation in experimental lung injury</article-title>. <source>Crit Care</source>. (<year>2010</year>) <volume>14</volume>:<fpage>R34</fpage>. doi: <pub-id pub-id-type="doi">10.1186/cc8912</pub-id>, <pub-id pub-id-type="pmid">20233399</pub-id></mixed-citation></ref>
<ref id="ref64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Kaczka</surname><given-names>DW</given-names></name> <name><surname>Andrews</surname><given-names>PL</given-names></name> <name><surname>Ghosh</surname><given-names>A</given-names></name> <name><surname>Al-Khalisy</surname><given-names>H</given-names></name> <name><surname>Camporota</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>First stabilize and then gradually recruit: a paradigm shift in protective mechanical ventilation for acute lung injury</article-title>. <source>J Clin Med</source>. (<year>2023</year>) <volume>12</volume>:<fpage>4633</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm12144633</pub-id>, <pub-id pub-id-type="pmid">37510748</pub-id></mixed-citation></ref>
<ref id="ref65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camporota</surname><given-names>L</given-names></name> <name><surname>Rose</surname><given-names>L</given-names></name> <name><surname>Andrews</surname><given-names>PL</given-names></name> <name><surname>Nieman</surname><given-names>GF</given-names></name> <name><surname>Habashi</surname><given-names>NM</given-names></name></person-group>. <article-title>Airway pressure release ventilation for lung protection in acute respiratory distress syndrome: an alternative way to recruit the lungs</article-title>. <source>Curr Opin Crit Care</source>. (<year>2024</year>) <volume>30</volume>:<fpage>76</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MCC.0000000000001123</pub-id>, <pub-id pub-id-type="pmid">38085878</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1846963/overview">Paolo Scanagatta</ext-link>, ASST Valtellina e Alto Lario, Italy</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0002">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1136733/overview">Ashraf Roshdy</ext-link>, Alexandria University, Egypt</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1305417/overview">Yuan Xueyan</ext-link>, Zhongda Hospital, Southeast University, China</p>
</fn>
</fn-group>
</back>
</article>